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ABSTRACT

The primary physiological pathway active during puberty is the hypothalmicpituitary-gonadal axis, but the factors or mechanisms involved in the activation of this
pathway are not well understood. Several mechanistic hypotheses have been set forth,
with this investigation focusing on the possible role for the adrenal glands in the theory of
adrenarche.
Peromyscus maniculatus has evolved a mechanism of population control that
appears to involve a disruption in pubertal transition. Previous work by our laboratory
has found distinct morphometric changes in the adrenal associated with puberty, and a
differing pattern in reproductively inhibited Peromyscus. To investigate these changes,
this study measured the expression of two genes involved in the steroidogenic pathway of
the adrenal before, during, and after normal pubertal transition, and in the special case of
the disrupted puberty found in reproductively inhibited animals.
Ribonuclease protection assays demonstrated increased adrenal expression of
hsd3bl and cypl7 at the time of puberty. In reproductively inhibited animals, hsd3bl
expression was not different than in normally maturing animals, but cypl7 expression
was statistically significantly reduced compared to similarly aged control animals.
The increased levels of hsd3bl and cypl 7 suggest increased adrenal production of
glucocorticoid and/or weak androgen at puberty. Normal levels of hsd3bl suggest
normal levels of corticosterone and aldosterone in inhibited animals, while reduced levels
of cypl 7 suggest reduced levels o f cortisol and/or weak androgen. The adrenal gland
appears to be involved in pubertal transition and the disrupted pubertal transition seen in
reproductively inhibited animals, but the exact role and extent of involvement is still not
clear.

ADRENAL EXPRESSION OF CYP17 AND HSD3B1
mRNA IN PEROMYSCUS MANICULA TUS BAIRDII
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Introduction and Literature Review

Overview
The significant evolutionary investment in reproduction is undeniable on any
level o f biological study. Behaviors have evolved that propagate reproductive success,
from courting rituals to aggression for mate selection in the animal kingdom; from
various forms o f taxis to parasitism in the kingdom monera; from chemical herbicides
and insecticides to symbiosis with bacteria or insects in the plant kingdom.

These

behaviors have all evolved to ensure that the individual will survive to obtain the
resources necessary to reproduce.

Physiologies governing reproduction are also often

complex and extensive, with nearly all bodily systems participating in some aspect of
reproduction. Entire organs or features are devoted solely to preparing for, participating
in, and/or ensuring or maintaining reproductive success.

These features, organs, or

systems often require a prodigious allocation of resources, an allocation that often places
reproductive success before personal long-term welfare.

The genetic and molecular/

cellular machinery devoted or associated with reproduction is equally impressive. The
complex cellular process o f meiosis has evolved expressly to allow contribution o f an
individual’s genes to a new generation.
In humans, there is great medical interest in understanding processes directly or
indirectly involved in reproduction. Ensuring a timely, disease-free pregnancy and birth
are the goals o f nearly all prospective parents. Additionally, as in nearly all species, the
human body becomes increasingly catabolic following the reproductively fertile period.
All beings pass their own genetic information on to new generations. Once the success of
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this transfer is ensured, there is little selective pressure to lengthen lifespan. There is an
obvious human desire to slow this genetically predisposed catabolism to extend lifespan,
and mechanisms underlying this senescence will be discussed in greater detail in later
sections.
While selective pressure on lifespan may be weak after reproduction, the
attainment o f reproductive capability has been strongly selected for, resulting in elaborate
maturational strategies. A first priority in these species appears to be the attainment of
that capability through maturation of the machinery primary to, or accessory to
reproduction. This may involve the development o f organs specific to reproduction, or
simply attainment o f the size or shape necessary to attract a mate or fend off threats to
reproductive success. This progression from reproductive adolescence to reproductive
maturity takes many forms, from the metamorphosis seen in insects to the pubertal
transition seen in mammals. While this reproductive maturation is nearly universal, and
critical to the propagation of life, the mechanisms governing its initiation and advance are
often poorly understood.
This thesis aims to advance our knowledge o f the mechanisms underlying
reproductive maturation through the study of components of pubertal transition in a
natural model, the prarie deermouse, Peromyscus maniculatus bairdii. Specifically, two
genes encoding enzymes essential to adrenal steroidogenesis are studied in relation to
pubertal transition to investigate a possible role in reproductive maturation and/or the
disruption of that maturation. Before presenting these investigations, it is necessary to
review pubertal transition in mammals generally, as well as the systems and processes
believed to be involved in puberty and reproduction in the deermouse.

4

Puberty
Puberty is not a single event, but rather a developmental period distinguished by
the attainment o f sexual maturity and fertility from an adolescent state.

Mammalian

puberty is characterized by the growth of reproductive organs, development of secondary
sexual characteristics, and the acceleration of growth (Sizonenko, 1987). In humans,
pubertal development is a process that lasts several years, with the majority of
development occurring between pubarche, or the first appearance of pubic and axillary
hair, to menarche, or the first menstruation (in females) (Wilson et al., 1998).
The physiological pathway that is primarily responsible for pubertal transition is
the hypothalamic-pituitary-gonadal (HPG) axis (Figure 1). In mammals, this axis is very
active in fetal life and immediate postnatal life, in particular when sexual differentiation
o f the fetus takes place (Brook, 1999). After approximately the second year of age in
humans, the HPG axis enters a quiescent period, only becoming active again at
approximately ten years o f age, or just prior to puberty. At this age, a pulsatile release of
gonadotropin-releasing hormone (GnRH) from the hypothalamus begins, with largest
spikes occurring at night (Sizonenko, 1987). These nocturnal peaks increase in amplitude
and frequency, causing the anterior pituitary to release increasing amounts of follicle
stimulating hormone (FSH), growth hormone (GH), leutenizing hormone (LH), but not
adrenocorticotropic hormone (ACTH). FSH and LH act to promote growth o f the testes
and ovaries, which correspondingly produce and release increasing amounts of androgens
and estrogens. These gonadal steroids propogate the development o f the sexual organs,
and primarily through augmentation of GH release, promote skeletal growth.
skeletal growth is mediated by growth hormone’s stimulation o f insulin-like growth

This
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Figure 1 - Hypothalmic-Pituitary-Gonadal (HPG) Axis. The physiological pathway that is primarily responsible for
pubertal transition is the hypothalamic-pituitary-gonadal axis. LH=leutenizing hormone, FSH=follicle stimulating
hormone, ACTH=adrenocorticotropic hormone, hGH=human growth hormone. From Sizonenko, 1987.

factor 1 (IGF-1 or somatomedin-C) production (Wilson et al., 1998).
The mechanism and factors responsible for the initiation of puberty are not
entirely understood, but likely involve a host of genetic and environmental factors
including nutrition and stresses.

Reactivation of the HPG axis after adolescent

senescence is clearly the control point for pubertal initiation, with the CNS being the
likely target o f initiation factors.

Hypothalamic GnRH releasing neurons begin their

pulsatile release o f pituitary stimulating hormone after a near decade (in humans) of
silence. While all mammals share a similar HPG mechanism for puberty, the initiators of
that reactivation are widely varied, representing diverse adaptive strategies in evolution
(Wilson et al., 1998). These initiators are currently a popular topic o f investigation.
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Receiving particular attention is the critical mass or critical fat theory o f pubertal
initiation.

The observation that obese humans reach menarche earlier, while

malnourished or extremely athletic individuals have delayed menarche, led to a critical
mass theory. Quite simply, the body will not undergo puberty if it does not have the
necessary energy stores. This was tested in rats nearly 40 years ago (Kennedy and Mitra,
1963), and has been documented in a host o f mammals since (Foster and Olster, 1985;
Frisch, 1994). Frisch (1977) showed that rats raised on a high fat diet reached first estrus
earlier than controls, but both groups had similar body fat composition once reaching first
estrus (Frisch et al., 1977).

Frisch (1994) also showed that female humans reach

menarche at different weights and heights, but tend to have similar body fat percentages
upon reaching menarche. The search for a molecule in adipose tissue capable of altering
the hypothalamus timing o f puberty led to the discovery of leptin (Zhang et al., 1994).
Zhang (1994) found that it was a homozygous mutation in the leptin gene (ob) that was
responsible for the obesity o f obese mice. Cunningham (1999) found that these mice are
also reproductively incapable, but can be restored to reproductive fertility through
peripheral injections o f recombinant leptin (Cunningham et al., 1999).

However,

initiation o f premature puberty in rats and mice through administration of exogenous
leptin has not been reproducable (Ahima et al., 1997; Cheung et al., 1997; Cunningham et
al., 1999).

Taken together, it appears that leptin is essential, but not sufficient, for

pubertal initiation.

A wide body o f investigations into leptin’s influence on the

hypothalamus has been undertaken.

While leptin receptors have been found in the

hypothalamus, there is no evidence that leptin directly influences GnRH secreting
neurons (Cunningham et al., 1999). Most likely, leptin relays the body’s metabolic state
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to GnRH neurons indirectly, by influencing other hypothalamic peptides (Cunningham et
al., 1999). Leptin also plays a role in the adrenal expression o f the steroidogenic enzyme
cy p l7. This influence will be discussed in a later section.
Obtaining proper levels of body fat is an important prelude to pubertal initiation,
but it is not the only determinant o f age of initiation.

Siberian hamsters, like other

seasonal breeders, also rely on detection of photoperiod to determine time of pubertal
development.

Adam et al. (2000) studied the regulation o f puberty and several

neuropeptides and their receptors in short and long day hamsters. Hamsters reared in a
short-day photoperiod normally show restricted growth and do not go through puberty,
while long-day animals grow rapidly and undergo pubertal transition.

Adam found

differences in leptin signalling and in activities of hypothalmic neuropeptide and receptor
systems in long and short day animals (Adam et al., 2000). Notably, higher levels of
leptin mRNA in adipose tissue, and leptin receptor mRNA in the hypothalamus of longday animals was detected by Northern blot and in situ hybridization.

Unfortunately,

these higher levels were not detected before the two groups diverged in body mass,
making it difficult to determine directionality o f leptin/ leptin receptor and body mass.
Leptin signalling o f a critical fat level does appear to be an important initiator of
puberty.

But like most physiological systems, this pathway is likely not the sole

contributor to pubertal initiation. The adrenal glands are also known to play a role in
puberty, though the extent o f that role is still not fully understood.

The theory of

adrenarche, or the puberty o f the adrenals, has received much attention in primates
(Cutler et al., 1978; Miller, 1999). Briefly, a major developmental change in the adrenals
prior to puberty leads to the substantial increase in adrenal production of several weak
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androgens.

Adrenal androgens can be converted to testosterone and/or estrogens in

peripheral tissues, and are believed to contribute to pubic hair growth, gonadal
development, and skeletal growth (Sizonenko, 1987). The extent of this contribution and
the role o f adrenal androgens in the maturation of the HPG axis remain speculative. But
before discussing adrenarche more fully, it is necessary to discuss the anatomy and
function o f the mammalian adrenal glands.

Adrenal Gland
The adrenal is an essential endocrine gland responsible for the production of a
variety o f hormones. In primates, the adrenals are located adjacent to the rostral surface
o f the kidney.

The anatomy of the mammalian adrenal can be divided into two

functionally and embryologically distinct tissues; a medulla consisting of neural crest
derived chromaffin, and a steroidogenic cortex arising from coelomic mesoderm of the
genital ridge (Figure 2) (Wilson et al., 1998).

The medulla is responsible for the

production o f the catecholamines epinephrine and norepinephrine, while the cortex is
responsible for the production o f the mineralcorticoid aldosterone, the glucocorticoids
cortisol and corticosterone (rodents), and the weak androgen dehydroepiandrosterone
(DHEA) (Wilson et al., 1998).

All adrenal cortex products are produced from the

substrate cholesterol, with the subsequent specific hormone production being dependant
upon the zone specific genetic expression o f substrate altering enzymes (Figure 3)
(Wilson et al., 1998).
The initial and rate limiting step in all adrenal steroid production is the cytosolic
transport o f free cholesterol to the inner mitochondrial membrane. While adrenal cells
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are capable o f producing cholesterol de novo from acetate or intracellular cholesteryl
ester, nearly 80% of utilized cholesterol is provided by circulating low density lipoprotein
cholesterol (Wilson et al., 1998). This substrate is internalized via cell surface, receptormediated endocytosis.

The invaginated vesicle fuses with lysosomes, within which

cholesterol is liberated by the hydrolysis of cholesteryl esters (Wilson et al., 1998).

Murine Adrenal Gland
zona glomemlosa
-mineralcorticoids

zona fasciculata
-glucocorticoids
-w eak androgens?

Medulla

zona reticularis
Cortex

-glucocorticoids
-w eak androgens?

Figure 2 - Murine Adrenal Gland. The mammalian adrenal is divided into a functionally distinct medulla and cortex.
The medulla is responsible for the production o f the catecholamines, while the further subdivided cortex produces a
variety o f steroids. The production o f weak androgens in murine species is not resolved.

Figure 3 - Adrenal Steroidogenic Pathway. The steroids produced from cholesterol are dependent upon the zone specific distribution of enzymes.
The lack of cypl7, and presence of 3|3HSD and cypl lb2 causes the production of the mineralcorticoid aldosterone in the zona glomerulosa. In
the mouse, the presence of 3PHSD, but not cyp l7 in the zona fasciculata facilitates the production of the glucocorticoid corticosterone. The
presence of cypl 7, but little 3(3HSD in the zona reticularis facilitates the production of the weak androgen DHEA. Schematic adapted from Wilson,
1998.
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Cholesterol delivery to the inner mitochondrial membrane is enhanced by the
presence o f several factors, most notably by the steroidogenic acute regulatory proten
(StAR) through an as yet undetermined pathway (Miller, 1998). ACTH also increases
delivery by increasing the number of LDL cell-surface receptors and increase of
cholesterol esterase (Wilson et al., 1998).

Conversion of cholesterol to pregnenolone

procedes via the cleavage o f the side chain at C2 0 . This reaction is catalyzed by the
NADPH dependant enzyme CYP11A l, the single product of the CYP11A1 gene. Further
conversion o f pregnenolone is dependant upon the zone-specific distribution of enzymes.
In the outer-most zona glomerulosa, the lack of the enzyme CYP17 (CYP17 gene
product), and the presence o f 3PHSD Type II (HSD3B2 gene product), causes the
conversion to proceed to progesterone.

The NAPDH dependant, microsomal enzyme

3pHSD catalyzes the dehydration of the 3-hydroxyl group of pregnenolone and the
isomerization o f the double bond at C5 to produce progesterone. The glomerulosa is the
only layer o f cells to possess the enzyme CYP11B2, the product of the gene CYP11B2.
This tissue specific distribution of enzymes allows the glomerulosa to be the sole
producer o f the mineralcorticoid aldosterone through the DOC to corticosterone pathway.
In the zonae fasciculata and reticularis, the presence of the enzyme CYP17
allows for the conversion o f pregnenolone to 170H pregnenolone or progesterone to
170H progesterone through hydroxylation o f C 1 7 . The same enzyme is also responsible
for the cleavage o f the carbon chain at C 17 , producing DHEA from 170H pregnenolone
or androstenedione from 170H progesterone.

The lyase conversion to DHEA or

androstenedione is determined by the presence or absence o f the necessary electron donor
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P450 Oxidative Reductase (OR) (Miller, 1998).

Alterations in the relative areas and

hormone output o f these two zones prior to puberty has raised debate regarding the
adrenals role in puberty. Albright (1947) first set forth the concept of adrenarche, which
implicates the adrenal in the pubertal transition.

Adrenarche
In humans, ‘adrenarche’ refers to the prepubertal rise in the secretion of the
adrenal androgens dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulphate
(DHEAS), and androstenedione (Albright, 1947; Miller, 1999).

The onset o f human

adrenarche corresponds approximately to the prepubertal rise in body mass index (BMI)
and the gradual increase in plasma insulin and insulin-like growth factor I (IGF-I)
(Rolland-Cachera, 1993; Smith et al., 1989).

Insulin and IGF-I augment adrenal

androgen production through altered expression of adrenal steroidogenic enzymes in
vitro, and an increase in BMI has been shown to reflect alterations in the biological
activities o f these peptides (Attia et al., 1998; Forbes et al., 1989; Frystyk et al., 1995). In
a longitudinal study o f 42 children, Remer (1999) found a significant correlation between
changes in BMI and onset o f adrenarche, providing evidence for possible in vivo
influences o f insulin and IGF-I on adrenal steroidogenic enzyme expression and adrenal
androgen production.
Levels o f plasma DHEA(S) in humans demonstrate a biphasic pattern of
prepubertal rise and postpubertal decline that is paralleled by IGF-I. DHEA(S) levels
remain low in children

2 -8

years of age, then rise dramatically at adrenarche to peak by
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age 20-25, followed by a steady decline until levels return to prepubertal levels by age 70
(Figure 4; Miller, 1999).

Human DHEA Production
400
350

•
♦

200

- - Male
■Female

-

150

g 100 o

0
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40
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80

100

Age (years)

Figure 4 - Human DHEA Production. Human DHEA production in males and females drops significantly at birth,
remaining at low levels until adrenarche. The significant rise at adrenarche continues until peaking at age 20-25, then
declines dramatically for the remainder o f life. This decline has been termed adrenopause. Figure redrawn from data
by Miller, 1999.

Clinical studies have shown that neither the gonad nor gonadotropins are
necessary for the onset o f adrenarche (Sklar et al., 1980), and so the physiological role of
adrenarche in humans remains unclear.

It has not yet been determined whether

adrenarche is a necessary prelude to puberty or a coincidental event. Recent studies of
DHEA replacement have shown that DHEA appears to enhance immunological
functions, stimulates bone formation, and increases the bioavailability of IGF-I (Kasperk
et al., 1997; Khorram et al., 1997).

DHEA(S) levels increase with prepubertal BMI

increases, possibly providing a homeostatic feedback to the increasingly anabolic body
through immunologic protection, bone formation, and increased IGF-I availability
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(Kasperk et al., 1997; Khorram et al., 1997).

Possible correlations with increasing

adrenal DHEA production and increasing levels of IGF-1 and BMI make the adrenal an
attractive candidate in the mechanism of puberty, but the extent of these interactions is
still confusing. The influence o f BMI on the adrenal and/or IGF-1 suggests a role for
leptin, and that role may be in the stimulation of the hypothalamus GnRH pulse
generator.

Adding to the confusion regarding a role for the adrenal in puberty is the

observation that normal puberty can develop without an adrenarche event (Sklar, 1980;
Miller, 1999).

These include primary adrenal insufficiency and idiopathic precocious

puberty (without precocious adrenarche) (Sklar et al., 1980). Clearly, greater study of
adrenarche must occur to clarify a role for the adrenal in puberty.
Unfortunately, studying adrenarche and then the subsequent drop in adrenal
androgens, or adrenopause, in humans is difficult due to the length of normal humans
lifespan. The biphasic pattern o f DHEA(S) production in humans has not been found in
rats, guinea pigs, hamsters, sheep, pigs, goats, horses, cows, or chickens (Cutler et al.,
1978). Rabbits and dogs have been found to show modest twofold changes, but only the
chimpanzee has been found to have the dramatic shifts in DHEA found in humans (Cutler
et al., 1978). Peromyscus species may have a DHEA pattern not seen in other rodent
species. Recent work by Hurst (1998) has shown adrenal expression of cypl 7, the gene
necessary for the production o f DHEA and the weak androgens, in P. leucopus (Hurst,
1998).
In addition to being a possible animal model for adrenarche, Peromyscus have a
mechanism o f population growth control that involves the disruption of normal pubertal
development.

Whether or not this disruption involves a possible adrenarche is not
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known, but elucidation o f the overall mechanism in Peromyscus may provide a clearer
understanding of reproductive disorders in humans.

Reproductive Inhibition in Peromyscus maniculatus
The prairie deermouse, Peromyscus maniculatus bairdii, exhibits little population
density fluctuation in both natural and laboratory populations (Terman, 1973b).
Population growth reaches a density-related, but not density-dependant growth asymptote
in laboratory populations provided with excess food, water, and shelter through reduced
survivability o f young, or more commonly, through cessation of reproduction (Terman,
1973b). More than 90% of young bom into these populations and surviving for at least
90 days will exhibit reproductive failure, with reproductive organ mass (ovaries, uteri,
testes, seminal vesicles) and body mass o f both male and female deermice remaining
significantly lower than in control populations (Terman, 1973b). The reduced body and
reproductive organ mass o f population deermice represents an incomplete sexual
maturation. A pubertal transition normally occurs between 40 to 60 days after birth in
control laboratory animals.

However, more than 90% o f the young bom into and

maintained within laboratory populations will remain juvenile in appearance and gonad
development (Bradley and Terman, 1981a; Terman, 1973b), and in addition will show a
reduction in active and resting metabolism rate for an indefinate period (Staubs and
Bradley, 1998).

This inhibition is reversible, with nearly 50% o f inhibited animals

reproducing within 30 days, and 75% within 80 days o f removal from a population
context and pairing (Terman, 1973a).

Accompanying the recovery o f reproductive

capability is the onset of adult patterns of metabolism and reproductive organ and total
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body mass consistent with a post-pubertal transition (Staubs and Bradley, 1998; Terman,
1973a).

This reversable inhibition indicates that the mechanism does not involve a

permanent early alteration to the hypothalamic-pituitary axis.
In a previous study by Teague and Bradley (1978), the existence of puberty
accelerating pheromone was discovered in the urine of male P. maniculatus. This factor
was found to be testis dependent, as the urine from castrated males did not elicite weights
different from controls. A later study by Terman (1984) found that the urine o f adult
females did not significantly alter the gonadal development of immature females, but
found physical contact significantly retarded growth of ovaries and uteri. Contact with
reproductively proven females or their urine was found to accelerate the reproductive
maturation o f immature males (Babb and Terman, 1982). Creigh and Terman (1988)
found that the presence o f reproductively proven females or their urine also increased the
testis and seminal vesicle mass o f inhibited males, promoting the reproductive recovery
o f those males in a fashion similar to the immature males studied by Babb and Terman
(1982).
A further study found a significant reduction in the serum testosterone of inhibited
animals compared to controls (Bradley and Terman, 1981b). This reduction was much
less (63% from controls) than expected from the severely reduced testis masses seen in
inhibited animals, leading the authors to speculate a possible role for the adrenals of
inhibited animals in producing androgen precursors. A comparison of adrenal histology
found a reduced mean adrenal mass in inhibited animals, but a trend towards larger
relative adrenal masses in these inhibited animals (Bradley and Terman, 1981a).
Corticosterone levels were also found to be significantly elevated in inhibited animals
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compared to controls o f both sexes. To investigate whether it is chronically elevated
ACTH levels or corticosterone levels that are contributing to reproductive inhibition,
Coppes and Bradley (1984) examined the effects o f exongenous ACTH and
glucocorticoid on the adrenal ultrastructure of inhibited and control male P. maniculatus.
They found that exogenous ACTH caused a hypertrophy o f the adrenal, and a
corresponding reduction in testis and seminal vesicle weight similar to that seen in
inhibited animals.

However, the ultrastructure o f the inhibited male’s adrenal zona

fasciculata differed drastically from that of control animals and animals treated with
exogenous ACTH.

Most notable was a gross alteration o f mitochondrial structure in

inhibited animals that was not seen in either other group. Serum ACTH levels were not
found to be significantly different in inhibited animals compared to controls.

These

findings suggested that ACTH alone does not promote the reproductive inhibition,
however it may play some role.
The depression in general growth and development of population animals
prompted Pitman and Bradley (1984) to investigate the role of the thyroid in inhibition.
Total serum thyroxine (T3) and thriiodothyronine (T4) were significantly lower in both
male and female inhibited animals when compared to controls.

A functional

hypothyroidism was found in both male and female inhibited animals through
gravimetric measurements. Kirkland and Bradley (1986) found a reduced mean serum
prolactin level in inhibited males and females. They suggested that these reduced levels
may be a consequence o f the previously observed reduction in thyroid hormones and
elevation o f corticosterone, both o f which have been shown to inhibit synthesis and
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secretion o f prolactin.

Whether the reduced levels o f prolactin were the cause or

consequence of reproductive inhibition was not determined.
In some other rodent species, density-related reproductive inhibition is
accompanied by a significant stress-induced adrenal gland hypertrophy (Calhoun, 1962;
Christian, 1956; Christian, 1955; Christian et al., 1965).

However, reproductively

inhibited P. maniculatus have been shown to exhibit gonadal regression and elevated
serum corticosterone concentrations, but without gravimetric evidence o f the adrenal
hypertrophy seen in other rodent species (Bradley and Terman, 1981c; Sung et al., 1977).
The apparent Peromyscus exception to the murine adrenal-associated population-stress
paradigm prompted Cherry (1998) to look more closely at the adrenal histology of
reproductively capable and inhibited animals before, during, and after the predicted
pubertal transition.

Cherry reported histogical changes in the adrenal that were

associated with the pubertal transition in control animals, as well as a distinctly
contrasting zona reticularis histology in reproductively inhibited deermice compared
with controls.

In particular, reproductively capable control animals had significantly

larger mean relative zona reticularis areas at prepubertal ages, followed by a decreased
zona reticularis post puberty. In contrast, reproductively inhibited animals maintained a
proportionally larger zona reticularis area at ages more than twice that o f the time of
normal puberty. Hence, there appears to be an association o f changed adrenal activity
with a delayed pubertal transition.
Cherry’s (1998) morphological observations suggest that the adrenals of maturing
P. maniculatus undergo functional changes, and that reproductively inhibited animals
have a different functional capacity. To investigate these possible functional changes, the
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study o f two genes involved in different steps of adrenal steroidogenesis were studied.
The expression o f these genes, cypl7 and hsd3bl, can be used to infer changes in
steroidogenesis o f the adrenals through normal puberty, and in the special case of the
disrupted puberty that is responsible for reproductive inhibition.

C YP 17

Biochemistry
Human

cytochrome

17oi-hydroxylase/17,20-lyase

(CYP17;

also

P450cl7)

catalyzes the 17a-hydroxylation o f pregnenolone to 17a-hydroxypregnenolone and
progesterone to 17a-hydroxyprogesterone. The same enzyme also catalyzes 17,20-lyase
activity to convert 17a-hydroxypregnenolone to dehyroepiandrosterone (DHEA), but
only in rodents is the 17a-hydroxyprogesterone to androstenedione conversion found to
be o f significance (Figure 5) (Lin et al., 1993).

Cloning
Cypl7 is encoded by a single gene, CYP17 (cypl7 in rodents), and a single
species o f mRNA (Miller, 1998). Human CYP17 has been mapped to chromosome lOq
24.3, and is found to exist as a single copy (Matteson et al., 1986). The cloning and
expression patterns o f CYP17 (cyplT) have been studied in a variety of animals. C ypl7
has been found in the gonads o f all animals studied, in the central nervous system of
embryonic mice and rats (Compagnone, 1995), as well as in the brain of mice and rats
(Stromstedt, 1995). Cloutier (1997) cloned hamster cypl 7, and found the cDNA to be
76% homologous in sequence to human CYP17.
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Cypl7 Steroid Conversions

Pregnenolone

170H Pregnenolone

DHEA

>
Progesterone

170H Progesterone

Androstenedione

Figure 5 - C ypl7 Steroid Conversions. The first conversion involves the hydroxylation o f carbon 17. The second
(independent) conversion involves the lyase conversion o f carbons 17 and 20. The upper series o f conversions are
referred to as the A5 pathway, while the lower are referred to as the A4 pathway, in reference to the double bond
position in ring 1. Schematic produced with CS Chemdraw Ltd. 3.1 (CambridgeSoft Corporation).

Transcriptional Regulation
Like other steroidogenic enzyme genes, the promoter of cypl7 contains a
consensus binding sequence for steroidogenic factor-1 (SF-1). Binding of SF-1 activates
transcription in cyp l7 and other steroidogenic genes. Hanley (2001) found three distinct
promoter elements for SF-1 binding and transcriptional regulation in human, rat, mouse,
pig, and cow. The nuclear orphan receptor DAX1 (dosage-sensitive sex reversal, adrenal
hypoplasia congenital, critical region on the X chromosome gene 1) has been shown to
colocalize with SF-1, and repress transcription of steroidogenic enzyme genes through
recruitment o f corepressors (including nuclear receptor corepressor N-CoR) (Hanley et
al., 2001). Interestingly, DAX1 has no transcriptional suppressive effect when only one
SF-1 binding site is ocupied. When two are occupied, weak suppression occurs, with
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strong repression occurring only when all three sites are occupied (Hanley et al., 2001).
Hanley suggests that fine tuning of transcription could occur through not only binding of
SF-1, but also other factors that could effectively compete for binding sites.
Through a cAMP mediated pathway, ACTH is known to upregulate transcription
o f cyp l7 mRNA within 4 hours o f exposure, but the exact mechanism is unknown
(Wilson et al., 1998). One proposed mechanism is through the interactions of SF-1 with
the cAMP-responsive proximal sequence (CRS2) and multiple coactivators (cAMP
binding protein and steroid receptor co-activator) or corepressors (DAX 1 and chicken
ovalbumin upstream promoter-transcription factors) (Lehmann et al., 2000). ACTH is
not believed to affect the 17,20-lyase activity of the cypl7 enzyme, as ACTH levels do
not increase with the corresponding increase in 17,20-lyase activity at adrenarche
(Biason-Lauber et al., 2000).

Functional Studies
Cypl7 is a microsomal protein found in cells o f the gonads and the adrenal zonae
fasciculata and reticularis, with only gonad and reticularis cells having both 17ahydroxylase and 17,20-lyase activities in humans.

This distribution permits the

fasciculata to produce C-21 steroids and cortisol, but not the C-19 steroids that may be
only synthesized by cells o f the reticularis and gonad. The dual enzymatic functions of
cypl7 are under independent regulatory control. Cortisol is synthesized throughout the
lifetime o f humans, necessitating a constant expression o f cypl 7. The adrenarche and
adrenopause phenomena suggest a temporal control of the 17, 20 lyase activity of cypl 7
necessary to synthesize DHEA.

A second hypothetical peptide hormone (cortical
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androgen

stimulatory hormone)

was

originally

suggested to

account for this

independantly regulated 17,20-lyase activity (Parker and Odell, 1980).

Independent

control o f 17,20-lyase activity is now known to be accomplished through regulation of
cy p l7 and P450 oxidoreductase (OR) interaction, an interaction necessary to mediate the
electron transfer from NADPH that is essential to 17,20-lyase enzymology (Lin et al.,
1993). Studies increasing the molar ratio o f OR to cypl 7 in transfected mammalian cells
resulted in increased ratios o f lyase to hydroxylase activity (Lin et al., 1993). This is also
the condition found in the testis, where a high molar ratio o f OR to cy p l7 leads to the
exclusive production o f C-19 steroids. Confirming this are studies inducing mutations in
the OR binding site, which resulted in decreased lyase activity without a paralleled
decrease in hydroxylase activity (Kitamura et al., 1991). Regulation of cypl7 and P450
OR interaction is .mediated through phosphorylation of cypl7 serine and threonine
residues by cAMP-regulated kinases (Miller, 1998).

These reactions alter the

electrostatic charge on the surface o f the cy p l7 protein in the region o f the OR binding
site, allowing greater OR interaction efficiency, and a subsequent increase in lyase
activity independent of hydroxylase activity (Miller, 1998).
Cytochrome b 5 has recently been implicated as an additional potential component
in the regulation o f the 17,20-lyase activity of cypl7 (Auchus et al., 1998; Mapes et al.,
1999).

Mapes et al. (1999) performed a immunohistochemical analysis of cypl7,

3pHSD, and bs distribution in the adrenals o f rhesus macaques.

Cypl 7 was found

throughout the fasciculata and reticularis, 3pHSD was restricted to the fasciculata, and
bs was restricted to the reticularis.

This distribution of bs is in accordance with the

necessary lack o f 17,20-lyase activity requisite to a cortisol-producing primate
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fasciculata, and abundance requisite to a weak androgen-producing primate reticularis.
Auchus et al. (1998) engineered yeast with inducible promoters to express human cypl7,
OR, or bs. Co-expression o f cy pl7 with bs resulted in a 10 fold increase in Vmax for
pregnenolone and progesterone conversion, but this increase existed only in the 17,20lyase portion o f the reaction.

Through analysis of xray crystal structures of OR and

cy p l7, Auchus (1998) proposed a model by which bs acts as an allosteric effector protein,
optimizing the geometry o f the cypl7-OR complex for the more sensitive 17,20-lyase
reaction. Hence, it appears that bs is not an essential component of 17,20-lyase activity,
but rather acts to enhance the activity of OR.
The peptide hormone leptin has also recently received attention for its possible
role in the independent control o f 17,20-lyase activity. Patients with leptin deficiency or
leptin resistance exhibit normal ACTH and cortisol levels, but do not produce sex
steroids, or subsequently undergo sexual development (Clement et al., 1998; Montague et
al., 1997). This suggests that the 17a-hydroxylase activity o f cy p l7 is intact, but the
17,20-lyase activity is somehow impaired.

Biason-Lauber et al. (2000) studied the

effects of leptin on cy p l7 activity in human adrenocortical cells. They found a direct
effect o f leptin on 17,20-lyase activity that was dependent upon intact leptin receptor and
an intact receptor signal transduction pathway.

The increased 17,20-lyase activity to

leptin treatment was immediate, and therefore appears to involve posttranslational
modification o f cy p l7 (Clement et*al., 1998; Montague et al., 1997) or an associated
protein such as OR, rather than transcriptional or translational alterations. Addition of
the protein synthesis inhibitor cycloheximide did not alter DHEA production, supporting
the authors hypothesis o f posttranslational involvement.

Leptin acts through a cell
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surface receptor, with transcriptional actions mediated through the JAK-STAT protein
phosphorylation pathway (Biason-Lauber et al., 2000). Phosphorylation is known to be
crucial to 17,20-lyase activity, and it may be that leptin’s effect on cypl7 involves
portion(s) o f this pathway (Clement et al., 1998; Montague et al., 1997).
C ypl7 has been implicated in the induction and maintenance of adrenarche and
adrenopause in humans. Miller (1999) has proposed that the upregulation o f 17,20-lyase
activity necessary to produce DHEA could be promoted by an increased biosynthesis of
OR, but this has thus far been unproven. In addition, IGF-1, whose levels parallel those
o f DHEA production, is also known to elicit numerous adrenal intracellular expression
changes through phosphorylation pathways and therefore may play a regulatory role in
cypl7 modifications in a fashion similar to serine/threonine kinases (Miller, 1999).
Regulation o f bs may also play a role, although no positive correlation between CYB5
(the gene encoding bs) expression and 17,20-lyase activity has yet been made (BiasonLauber et al., 2000).
Most rodent species produce corticosterone as their primary glucocorticoid,
therefore not requiring expression o f cypl 7 in the adrenals. Cypl 7 has been found in the
adrenals o f hamsters (Cloutier, 1997), guinea pigs (Tremblay, 1994), in Peromyscus
leucopus (Hurst, 1998) and now in this study, Peromyscus maniculatus. The presence of
cypl 7 in the adrenals o f hamsters is not surprising, as cortisol is their primary
glucocorticoid. Using immunolocalization of anti-rat cypl 7 antibody, Briere et al. (1997)
found the zona fasciculata to be the sole producer of the cypl 7 enzyme in the hamster. A
dose dependent increase in cy p l7 expression with ACTH stimulation was found through
immunolocalization as well as western blotting assays, with the zona fasciculata again
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being the significant zone o f expression in hamsters (Briere et al., 1997). Additionally,
immunocyctochemistry with colloidal gold showed a predominance of cypl7 present in
intermitochondrial spaces corresponding to the endoplasmic reticulum (ER).

ACTH

stimulation showed an increased ER staining with no increase in zona fasciculata area,
suggesting increased cellular activity of cypl 7 without cellular proliferation (Briere et al.,
1997). Cloutier et al. (1997) characterized hamster adrenal cypl 7 through cloning and
transient expression studies, and cypl7 through immunoblotting studies. They found that
hamster cypl 7 cDNA was 76% homologous to that of human, and when transfected in an
expression vector into COS 1 cells it was capable of converting pregnenolone to 17ahydroxypregnenolone to DHEA as well as progesterone to 17a-hydroxyprogesterone to
androstenedione. Using cell suspensions and microsomal preparations, Cloutier found
both DHEA and pregnenolone were produced, but found their intermediates (17ahydroxypregnenolone and 17a-hydroxyprogesterone) produced at much higher molar
ratios.

These results indicate that the hamster adrenal is both a cortisol and DHEA

producer, with the maintenance of 17a-hydroxylase activity significantly higher than
17,20-lyase activity, suggesting that more cortisol is produced compared to DHEA.
Cortisol is also the primary glucocorticoid produced by the guinea pig. In a study
o f zonal distribution o f cypl 7 in the guinea pig adrenal, Shinzawa et al. (1988) found
immunolocalization o f cypl7 in both the zonae fasciculata and reticularis, with the
majority located in the outer fasciculata. Addition of ACTH to microsomal fractions
resulted in increased 17a-hydroxylase activity in both the zonae fasciculata and
reticularis, but did not affect 17,20-lyase activity in either zone. These data suggest that
the synthesis o f cortisol, but not weak androgen, is upregulated in the intact guinea pig
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adrenal upon ACTH stimulation. Tremblay et al. (1994) performed similar distribution
and substrate studies on the cypl 7 gene in guinea pig adrenals. To determine enzyme
activities and substrate specificity, full length cypl 7 cDNA was inserted into an
expression vector and transfected into COS-1 cells.

Tremblay found both 17a-

hydroxylase and 17,20-lyase activity when incubated in vitro with pregnenolone or
progesterone, though progesterone conversion was extremely low. To confirm the A4
pathway (pregnenolone substrate) preference in vivo, the authors transfected the full
length cy p l7 cDNA into primary adrenocortical cell culture while blocking the 3pHSD
activity through-administration o f trilostane. The result was only a 12% conversion of
the A5 pregnenolone to 17a-hydroxypregnenolone, confirming the A4 substrate specificity
that is thus far novel to the guinea pig. Interestingly, very low levels o f the A4 pathway
intermediate 17a-hydroxyprogesterone were detected, leading the authors to suggest the
17,20-lyase reaction to proceed more rapidly than the 17a-hydroxylation reaction.
Supporting this is the significantly higher cypl7 reaction Vmax of 24.4 pmole/min-mg for
17a-hydroxyprogesterone, versus 1.4 pmole/min-mg for progesterone.

The authors

hypothesize that it is the 17a-hydroxylation that is rate-limiting, and that the cypl7
enzyme does not dissociate from the substrate between 17a-hydroxylation and 17,20lyase reactions.
Preliminary gene expression studies by Hurst (1998) and Powers (1999) suggest
that cypl 7 is expressed in the adrenals of Peromyscus species. The presense of cypl 7 in
the adrenals o f Peromyscus suggests that either low levels o f cortisol, or possibly C-19
steroids such as DHEA, are being produced by the Peromyscus adrenal. The significance
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o f this gene expression or hormone synthesis by the Peromyscus adrenal is currently
under evaluation.

HSD3B1

Biochemistry
3p-hydroxysteroid dehydrogenase/isomerase (3pHSD) catalyzes the conversion
o f A5 -3p-hydroxysteroids to A4 -3-ketosteroids, an obligate step in the biosynthesis of all
biologically active adrenal steroid hormones. In the adrenal cortex, 3PHSD is necessary
for the production o f the mineralcorticoid aldosterone, the glucocorticoids cortisol and
corticosterone, and the weak androgen androstenedione (Wilson, 1998). In the gonads
3pHSD is required for conversion o f the weak androgen DHEA to the more active
testosterone or estrogen.

The dehyrogenase and isomerase activities are linked on a

single dimeric protein, with no isolatable intermediates found during the A5 -3phydroxysteroid to A4 -3-ketosteroid conversion (Mason et al., 1998). 3pHSD is an NAD+
or NADPH dependent, membrane-bound protein closely associated with the endoplasmic
reticulum and mitochondrial membrane of traditional steroidogenic tissues (adrenal,
gonads, and placenta) (Mason et al., 1997).

The enzyme is additionally found in

nonsteroidogenic tissues such as the kidney and liver, where it appears to catalyze the
formation or degradation o f the 5a-androstanes and 5a-pregnanes (Zhao et al., 1991).

Cloning
At this time two functional and five pseudogenes have been characterized for
HSD3B1 in the human genome (McBride, 1999; McCartin, 2000), while five and six

28

functional genes and one pseudogene have been identified in the rat and mouse genomes
respectively (Payne et al., 1997). Human HSD3B exists as a cluster of genes located on
chromosome lp 13.1 (McCartin, 2000), while the seven mouse hsd3b genes have been
found in a cluster on chromosome 3 between Tshb and Gba (Payne et al., 1997). The
HSD3B gene family is thought to have arisen through gene duplication o f a single
ancestral HSD3B gene (McBride et al., 1999). Six murine cDNAs (from six separate
genes) exhibiting a high degree o f amino acid identity (between 72 and 93% amino acid
identity) have been isolated to date (Figure

6

) (Abbaszade et al., 1997; Payne et al.,

1997).

M us m useulus 3pHSD Amino Acid Homologies (%)

Type I
Type II
Type III
Type IV
Type V

Type II

Type III

Type IV

Type V

Type VI

84

83
93

77
75
73

74
72
72
93

84
91
91
74
72

Figure 6 - Mus musculus 3PHSD Amino Acid Homologies. The six cDNAs arise from six separate hsd3b genes, and
fall into two groups based on amino acid homology and functionality. cDNAs I, II, III, and VI act as NAD+ dependent
dehydrogenase/ isomerases and are 83-93% similar in amino acid sequence. cDNAs IV and V function as NADPH
dependent 3-ketosteroid reductases and share 93% amino acid sequence identity. Figure from data by Abbaszade,
1997.

All o f the murine cDNAs contain a 1119 bp open reading frame encoding a protein of
373 amino acids (Payne et al., 1997). The six murine cDNAs fall into two groups based
on substrate specificity and activity (Figure 7).

cDNAs I, II, III, and VI function as

NAD+ dependent dehydrogenase/ isomerases and are 83-93% similar in amino acid
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sequence (Payne et al., 1997).

cDNAs IV and V function as NADPH dependent 3-

ketosteroid reductases and share 93% amino acid sequence identity (Payne et al., 1997).
cDNAs were named based on their chronological discovery creating confusion, with
murine type I being homologous to human type II, and mouse type VI being homologous
to rat type IV and human type I. Murine type I (human type II) 3pHSD is predominantly
found in the adrenals and gonads, where it is responsible for the biosynthesis of active
steroids. Type I is additionally found in the kidney, fat tissue, and placenta o f rodents
(Payne et al., 1997). Type II and III have been isolated from murine kidney and liver
tissue, with type III being the dominant cDNA expressed in the adult liver (Payne et al.,
1997). Type III is the major NAD+ dependent cDNA expressed in the adult rodent liver,
and may be important in the production o f steroid hormones in the case of adrenal or
gonadal genetic deficiencies (Payne et al., 1997). In mice, type IV is found exclusively
in the adult kidney cortex, with a predominance of expression in the proximal convoluted
tubles (Payne et al., 1997). Type V is expressed only in the male rodent liver, where, like
type IV in the kidney, it is most likely involved in the deactivation of active steroid
hormones (Zhao et al., 1991). Mouse type VI (rat type IV, human type I) is principally
expressed in the placenta and sebaceous glands of skin (Abbaszade et al., 1997). In the
placenta, type VI functions to locally synthesize progesterone from pregnenolone, a
conversion that is essential to blastocyst implantation and maintenance of pregnancy
(Abbaszade et al., 1997).
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30HSD Steroid Conversions

3P-hydroxysteroid dehydrogenase/ A5-A4isomerase
Murine
Type
I, II, III, VI
Pregnenolone

Progesterone

DHEA

Androstenedione

3-ketosteroid reductase

Murine
Type
IV, V
Dihydrotestosterone

5a-Androstane-3p, 17P~diol

Figure 7 - 3PHSD Steroid Conversions. cDNAs I, II, III, and VI act as NAD+ dependent dehydrogenase/ isomerases,
while cDNAs IV and V function as NADPH dependent 3-ketosteroid reductases. Schematic produced with CS
Chemdraw Ltd 3.1 (CambridgeSoft Corporation).

Expression
Like other adrenal steroidogenic enzyme genes, 3pHSD contains a putative
consensus binding element for the transcription factor, steroidogenic factor 1 (SF-1)
(Mason et al., 1997). This 9 base pair element (TCAAGGTAA) lies 64 to 56 base pairs
upstream o f the human type II promoter but not that o f human type I. The functionality
o f this element has been demonstrated through transient transfection with promoter-CAT
constructs containing intact or mutated element sequence (Mason et al., 1997). LeersSucheta et al. (1995) found that expression was only induced by phorbolester in the
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presence o f intact SF-1 binding element constructs. The authors also found expression to
be enhanced by cotransfection with a SF-1 encoding expression vector, lending support
to the element’s putative transcriptional role (Leers-Sucheta et al., 1995). The lack of
this element in human type I is in accordance with its expression in only placental tissues,
where the trancription factor SF-1 is not found. Interestingly, the rat adrenal cDNA (type
I) sequence demonstrates significant divergence in the area of the SF-1 bindings site from
human (type II) (Leers-Sucheta et al., 1995).

The crucial core sequence (AAGG) is

found at other places in the first intron, and it is not known if these areas, or the divergent
putative binding site are able to mediate SF-1 transcription effects (Leers-Sucheta et al.,
1995). As in cypl 7, DAX1 is capable o f repressing hsdSbl transcription by binding to
SF-1 and recruiting corepressors. However, the single SF-1 binding domain found in
human and mouse adrenal hsd3b is not significantly repressed (Lalli et al., 1998).
Hanley’s (2001) observation that an increased number o f SF-1 elements binding to the
promoter o f cypl 7 increased DAX1 inhibition suggests that the single hsd3b consensus
sequence allows it and cypl 7 to be differentially transcribed by SF-1 and DAX1
interaction.
Doi et al. (2001) investigated the effects of epidermal growth factor (EGF) and
basic fibroblast growth factor (bFGF) on HSD3B (human type II, murine type I) and
CYP17 expression in human adrenocortical carcinoma cells. They found that both EGF
and bFGF induced mRNA production of 3PHSD while suppressing CYP17 production.
Similar to the time course seen in ACTH-induced expression o f 3PHSD and CYP17,
EGF and bFGF induction did not occur until approximately

6

hours after treatment (Doi

et al., 2001). This induction was determined to require de novo protein synthesis, as
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treatment with the protein synthesis inhibitor, cycloheximide, abolished these effects (Doi
et al., 2001). The pathways by which these factors effect HSD3B and CYP17 expression
are still not understood, though CaMK II and MAPK signalling pathways are indicated to
be important based on results from treatments manipulating pathway intermediates (Doi
et al.,

2001

).

Functional Studies
In humans, fifteen missense mutations have been reported in the gene encoding
3pHSD type II that result in altered adrenal and gonadal ouput (McCartin et al., 2000).
Several null mutations lead to congenital adrenal hyperplasia (CAH), characterized by
reduced levels o f glucocorticoids, sex steroids, and loss o f aldosterone, with subsequent
severe salt wasting (McCartin et al., 2000). Less severe mutations have been identified
that allow sufficient production o f aldosterone, but not that of the sex steroids. The loss
o f testosterone production in these males leads to pseudohermaphroditism, while the loss
o f estrogens in these females can lead to virilization or premature puberty (McCartin et
al., 2000).

Interestingly, McCartin et al. (2000) reported the first case o f premature

adrenarche in a male with 3pHSD type II deficiency. This observation supports Miller’s
(1999) hypothesis that a 3pHSD decline results in the elevated adrenal DHEA paramount
to adrenarche.

Residues Cysl82 and His261 are believed to be the active sites of

substrate binding and isomerase activity on human type II 3PHSD, as evidenced from
mutation studies (Strickler et al., 1993) and affinity labelling with radiolabelled substrate
(Thomas et al., 1993). O f the fifteen missense mutations clinically reported thus far, six
are adjacent to one o f these residues (McCartin et al., 2000).
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In adult humans, 3pHSD type II is located predominantly in the zonae
glomerulosa and fasciculata. A lack of 30HSD activity in the adult reticularis predicates
the production o f the weak androgen DHEA and not cortisol. This is also the condition
found in rhesus macaques and other nonhuman primates (Mapes et al., 1999).

Two

studies have provided evidence that adrenarche is related to age-related changes in the
expression o f 3pHSD type II (murine type I) in the human adrenal. Gell et al. (1998)
utilized an antibody for 3pHSD to study changes in enzyme expression in the adrenals of
38 autopsy patients from 4 months to 56 years in age. They found a significant decline in
3pHSD production in the reticularis of children age 8-13, and a continued gradual
decline in reticularis 3PHSD beyond 13 years o f age, with no corresponding change in
either the fasciculata or glomerulosa (Gell et al., 1998). Dardis et al. (1999) examined
total adrenal RNA extractions o f 11 individuals for 3pHSD type II expression using RTPCR.

They found a similar decrease in 3pHSD expression in the older of the two

groupings, suggesting the same overall decline in 3PHSD production following
adrenarche and puberty that Gell (1998) observed (Dardis et al., 1999). In a study of
premature pubarche (the appearance o f pubic hair), Marui et al. (2000) identified two
mutations in HSD3B2 that led to premature pubarche and elevated ACTH-stimulated
170H-pregnenolone production. This elevated 170H-pregnenolone is likely a result of
decreased 3pHSD competition on CYP17, and given the subsequent premature pubarche,
provides additional support for the importance o f altered 3pHSD expression with
adrenarche.
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In contrast to humans, adrenal expression of 3pHSD is found in all three cortical
zones o f rats.

As in humans, rat adrenal 3pHSD is upregulated by ACTH and

downregulated by glucocorticoid administration (Pignatelli et al., 1999). Pignatelli et al.
(1999) utilized an antibody for 3pHSD type I (human type II) to study the postnatal
ontogeny o f 3pHSD in the adrenal glands of rats. The inner and outer fasciculata were
found to exhibit 3PHSD activity from birth, with both increasing in staining intensity to
pubertal ages.

The glomerulosa and reticularis were slower to develop, with the

reticularis showing no 3pHSD activity until 10-18 days after birth, and both showing
increasing activity until time o f predicted puberty. However, this study did not focus on
the pubertal transition, and lacked any conclusive data relating 3PHSD activity to
pubertal transition.
3pHSD was found to be distributed throughout the hamster adrenal cortex
through the use o f immunohistochemistry with a rabbit anti-human placental 3PHSD
antibody (Rogerson et al., 1998). The kinetics of pregnenolone and DHEA conversion by
3PHSD in hamster adrenal cell homogenates was also measured. Interestingly, 3pHSD
displayed a higher affinity for DHEA than pregnenolone as substrate. Rogerson (1998)
suggests that DHEA levels in hamster adrenals are significantly lower than pregnenolone,
as evidenced by the substantially lower levels of cypl7 compared to other steroidogenic
enzymes, necessitating a high affinity for efficient conversion of DHEA. This is not the
case in rat and mouse, where cy p l7 is not present, and affinity o f 3PHSD is much higher
for pregnenolone (Simard et al., 1996).
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Concluding Remarks and Hypothesis
The physiological differences Terman (1973), Bradley and Terman (1981a,b,c),
and Staubs and Bradley (1998) found between reproductively capable controls and
reproductively inhibited Peromyscus maniculatus collectively suggest that reproductive
inhibition acts in part through a delayed pubertal transition.

The adrenal differences

Bradley and Terman (1981c) and Cherry (1998) described between reproductively
capable controls and reproductively inhibited P. maniculatus suggests an association of
changed adrenal activity with a delayed pubertal transition.

However, the nature and

consequence o f these adrenal morphometric changes is not understood.

Presumably,

alterations in the zonation o f the Peromyscus adrenal results in altered output as other
investigators have shown in other species (Colby et al., 1993; Dardis et al., 1999; Gell et
al., 1998; Mapes et al., 1999). The small size o f the P. maniculatus adrenal makes the
study o f hormone production difficult by current practices. However, through the study
o f the genes requisite to their production, alterations in adrenal output can be inferred.
Previous to this study, the adrenal expression patterns of hsd3bl and cypl 7 were
unknown in Peromyscus maniculatus.
While these genes and their proteins have been studied in a number o f other
species, current documentation o f gene and protein expression correlated with puberty is
limited (Figure 8 ). In humans, adrenarche and the onset of puberty have been correlated
with decreased expression o f hsd3b and 3pHSD in the zona reticularis. Concurrently,
the expression o f c y p l7 does not change, but the relative 17,20-lyase activity of cypl7
increases dramatically in the zona reticularis (Miller, 1999). A pubertal time course of
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hsd3b or its protein in the guinea pig is currently unpublished. Enzyme activity assays
have found an increase in cypl 7 activity in the zona fasciculata, while a decrease was
found in the zona reticularis (Colby et al., 1993). This study was limited to observations
made at 35, 100, and 200 days o f age, and therefore only included prepubertal, and post
pubertal observations, and only the 17a-hydroxylase activity o f cypl7 was measured (to
investigate cortisol production), therefore neglecting possible DHEA production through
additional 17,20-lyase activity. There are no reports in the literature o f studies of cypl 7
in the adrenals of rat and mouse.

3[3HSD has been studied in the adrenals of both

species, but only in rat has pubertal transition been addressed. Pignatelli (1999) found
increased levels of 3(3HSD as rats approached puberty, but, this study ended at 40 days of
age, and therefore did not detect possible pubertal changes.

Currently Documented Patterns of Adrenal cyp!7 and hsd3b in Pubertal Transition
cypl 7

hsd3b

Comments

Human

No differences in
protein or mRNA

4 protein in ZR
4 mRNA in total adrenal

change in cyp involves
t 17,20-lyase activity, not
expressional changes

Guinea Pig

T in ZF 4 in ZR
(enzyme activity)

Currently unknown

cyp enzyme assays on 35d
& lOOd animals only
(prepubertal & adult only)

Rat

*cyp expression
not reported

t protein in ZF & ZR

study ended at 40d of age
(likely prepubertal)

Mouse

*cyp expression
not reported
Currently unknown

Currently unknown

Hamster

Currently unknown

Figure 8 - Currently Documented Patterns o f Adrenal cyp l 7 and hsd3b in Pubertal Transition. While cyp l 7 and hsd3b
have been studied in all species above, current literature documenting pubertal changes in adrenal cyp l 7 and hsd3b are
limited. Relative levels o f protein and mRNA at puberty are listed above when reported ( t indicates increased levels at
puberty, 4 indicates decrease levels at puberty). ZR= zona reticularis, ZF= zona fasciculata, *cyp!7 is not expressed in
rat or mouse adrenals, studies are cited in text.
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Clearly, there is a lack o f studies investigating the changes in cyp 17 and hsdSbl,
and their enzyme products in the adrenals of murine species. The hsdSbl gene product
(3pHSD) is essential to the production of all active adrenal steroids, and is therefore
believed to be an indicator o f overall adrenal activity. The cyp 17 gene product (cypl 7) is
essential to the production o f adrenal cortisol and/or weak androgen. These two genes
represent an important branch point in steroidogenesis, and their expression may indicate
functional changes in the adrenal during both maturation and reproductive inhibition.
The expression pattern o f these genes will be investigated in the adrenals of
normally maturing male Peromyscus maniculatus before, during, and after pubertal
transition using the ribonuclease protection assay. Because puberty is likely to be a time
o f increased metabolic demand requiring glucocorticoid, and possibly weak androgen
production for sexual maturation, we hypothesize that both adrenal hsdSbl and cyp 17
will show increased expression during normal pubertal transition. We will also study the
expression pattern o f the same two genes in a naturally occurring mechanism of pubertal
dirsuption (reproductive inhibition) and compare their expression to the normal
maturational time course expression. Because reproductive inhibition does not disrupt
the ability o f the adrenal to maintain mineral balance or to produce corticosterone
(Bradley and Terman, 1981c), our second hypothesis is that expression of hsdSbl in
reproductively inhibited animals will not be significantly different than similarly aged
controls. However, due to the impaired sexual maturation characteristic o f reproductive
inhibition, we hypothesize that reduced expression of weak androgen producing cypl 7
will be found in reproductively inhibited animals compared to controls.
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Materials and Methods

Animal Maintenance
Animals used in this study were prairie deermice (Peromyscus maniculatus
bairdii) obtained from our outbred production colony (Bradley and Terman, 1981a;
Bradley and Terman, 1981b; Bradley and Terman, 1981c). All animals were maintained
within an annual temperature range o f 23+4°C and exposed to fluorescent lighting that
averaged 120 lux at the floor and 160 lux at the height o f individual cages. Lighting for
all studies was provided for 14 hours followed by a daily dark period between

2000

h and

0600h. All production colony and selected control animals were maintained in wiretop
plastic cages measuring 12.8 x 27.8 x 14.5 cm on wood shavings in same-sex sib groups
following weaning (2Id). Food (Prolab Rat, Mouse, Hamster 3000, Agway, Inc.) and
water were provided ad libitum.
Reproductively capable control animals constituted non-sibling males selected
from different litters at the specific ages of 30, 50, 70 (±2), 90 (±3), and 120 (±5) days.
To create a representative sample and to permit continued production o f animals within a
fairly constant population context only two animals were sampled from any single litter.
Reproductively inhibited animals were obtained from growing “laboratory
populations” by methods that have been previously described in detail (Bradley and
Terman, 1981a; Bradley and Terman, 1981b; Bradley and Terman, 1981c). Briefly, two
populations were established within 1.5m diameter enclosures with four pairs of
reproductively proven animals.

Young produced within the population were checked
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every two weeks for reproductive condition.

Reproductively inhibited animals were

selected by lot for study from among appropriately aged animals only if they had never
displayed a scrotal testes.

To create a representative sample and to permit continued

production o f animals within a fairly constant population context only two animals were
sampled from any single litter.

Organ Sampling
Adrenal glands were removed from control male P. maniculatus at ages 30, 50, 70
(±2), 90 (±3), and 120 (±5) days (n=5 per age group) and reproductively inhibited male
P. maniculatus at 130 (±10) days (n=5). Animals were sacrificed by cervical dislocation
with decapitation and immediately weighed prior to adrenal removal.

A longitudinal

abdominal incision was made and the adrenals were removed, cleaned of fat and
connective tissue, and then weighed to the nearest
nitrogen.

0 .1

mg before rapid freezing in liquid

Testes and seminal vesicles were dissected and fixed in 10% buffered

formaldehyde and weighed to the nearest 0.1 mg after complete dehydration. There were
never more than two siblings sampled for each age group.

Animals were kept

undisturbed in their home cage until the moment of sacrifice to limit possible adrenal
stress response.

RNA Isolation
Total RNA from male P. maniculatus adrenal and testis pairs was extracted with
GITC (Sambrook et al., 2001). Briefly, RNA was extracted with phenol/chloroform and
precipitated in isopropanol. DNA was removed with 0.5pi RNase-ffee DNase (lOU/pl,
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Promega, Madison, WI), followed by a second round of phenol/chloroform extraction
and ethanol precipitation. The concentration and purity of total RNA was determined
through denaturing gel electrophoresis and optical density measurement at 260 and 280
nm with a GeneQuant Pro (Amersham Pharmacia Corp.).

DNA Isolation
Genomic DNA from male P. maniculatus brain and testis was extracted by a
protocol from Sambrook et al., 2001. Briefly, tissues were homogenized in a digestion
buffer containing 0.1 mg/ml proteinase K (Promega, Madison, WI). DNA was extracted
with phenol/chloroform twice and ethanol precipitated.

RNA was removed with 2pl

RNase A (40pg/ml, Ambion, Austin, TX), followed by phenol/chloroform extraction,
chloroform/isoamyl alcohol extraction, and ethanol precipitation. The concentration and
purity o f genomic DNA was determined through gel electrophoresis.

Cloning
A 129 base pair fragment from exon 3 of murine Type I hsd3b (hsd3bl) was
isolated through PCR amplification of P. maniculatus genomic DNA with the forward
primer

5’

TAGTGTGTTCACCTTCTCCTA

3’

and

reverse

primer

5’

TGTCTCCTTGTGCTGCTCCAC 3’ and cloned into Bluescript KS+ vector (Stratagene,
La Jolla, CA). A 252 base pair fragment, comprising 81bp of 5’ upstream sequence and
171bp o f exon 1 o f cypl 7, was isolated through PCR amplification of P. maniculatus
genomic DNA with the forward primer 5’ AAGAGATAACACAACTTCAAG 3’ and
reverse primer 5’ CCGTGTCTGGGGAGAAACGGC 3’ and cloned into Bluescript SK+
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vector (Stratagene, La Jolla, CA). Sequence information was confirmed through manual
sequencing by the Sanger dideoxynucleotide method (Sanger et al., 1977) using the
Sequenase 2.0 kit (USB Corp., Cleveland, OH), as well as through automated sequencing
using a Licor Model 4200 (Licor, Lincoln, NE) and Sequitherm Excel II Long-Read
DNA Sequencing Kit LC (Epicentre Technologies, Madison, WI) according to
instructions provided by the manufacturers. Sequences were analyzed with Omiga 2.0
(Oxford Molecular) and were found to be highly homologous to published rodent and
human sequences for adrenal hsd3b and cyp 17 (complete sequences and alignments can
be found in Appendix A).

Ribonuclease Protection Assay
The hsd3bl and cypl 7 containing recombinant plasmids were linearized with
BamHI and labeled with
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P-aUTP (Perkin Elmer/ NEN, Boston, MA) using T3 RNA

polymerase for hsd3bl and T7 RNA polymerase for cyp 17 to yield antisense probes
(BamHI, T3, T7, Promega, Madison, WI). The internal control, pTRI RNA 18S (an
antisense 18S ribosomal probe, Ambion, Austin, TX), was transcribed using the T7
Shortscript Kit (Ambion, Austin, TX) according to manufacturers instructions.

Sense

probes for hsd3bl and cyp 17 were transcribed by the same method, using Hindlll
linearizations for both, T7 polymerase for hsd3bl, and T3 polymerase for cyp 17. Probes
were purified on a 6% polyacrylamide denaturing gel, excised, and eluted for 4 hours.
Five to 20pg testis total RNA and complete adrenal pair total RNA (typically 10-15 jig)
were hybridized with 5x l0 4 cpm o f cyp17 (365bp probe; 171bp protected fragment) and
hsd3b (242bp probe; 129bp protected fragment) cRNA probes, and 1260ng pTRI RNA
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18S cRNA (120 bp probe; 80bp protected fragment) probe for 10-12 hours at 50°C.
Digestion with RNase A and T1 (40pg/ml and 2pg/ml respectively, Promega, Madison,
WI) at 37°C for 30 minutes was followed by enzyme deactivation, phenol/chloroform
extraction, and precipitation. RNA was separated on a 6% polyacrylamide denaturing
gel, with autoradiography (Fuji RX) exposed at -80°C with an intensifying screen
(complete RPA procedure can be found in Appendix B).

Ribonuclease Protection Assay Analysis
Films for the four assays were scanned as tif files and then quantified through
scanning densitometry using NIH ImageJ vl.2h (see Appendix B for complete protocol).
Briefly, regions o f interest were selected to include the differing shapes of protected
fragments, and therefore differed in length and height accordingly.

However, as the

analysis software determines average pixel density, regions o f interest were identical in
the total number o f pixels. Sense transcripts were run as negative controls, as were lanes
containing all probes with no RNA. The protected fragments for each cypl 7 and hsd3bl
band were normalized for RNA loss by comparison with the corresponding 18S
ribosomal band density, and expressed as a ratio with the ribosomal signal. The first of
the four assays utilized 3pCi o f

P-labelled UTP in the transcription of the ribosomal

probe. To optimize protected fragment visualization,

'X'y

P-labelled UTP was increased to

lOpCi for the remaining 3 assays. To allow for comparison o f the four runs, ribosomal
values for the first assay were therefore normalized to the other assays by multiplying by
3.33. The manufacturer o f the ribosomal control reports this probe to often produce two
closely migrating protected fragments, the larger at 80bp, due to the rehybridization o f a
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portion of the antisense probe following denaturation. This phenomena appears to be
correlated to the large mass of 18S ribosomal RNA in reactions containing more than
0.5pg total RNA, and the manufacturer suggests including both bands when quantifying
the intensity o f signal.
The masses of protected fragments were evaluated in duplicate in a separate assay
hybridizing known masses of the sense transcripts of hsd3bl and cypl7 with excess
antisense probe (Figure 9).

lOOpg
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lpg

lOOfg
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lng

500pg
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I

I
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w

*

B) hsd3bl

Figure 9 - Quantitative RPA. Protected fragment masses were determined through a separate assay utilizing optical
density measured sense transcript templates o f A) cypl 7 and B) hsd3bl performed in duplicate. Sense transcripts of
known masses were hybridized with excess antisense probe. Cypl 7 exposure of 2 weeks, hsd3bl exposure o f 6 hours.

Statistical Analysis
All data were analyzed by separate one-way ANOVA.

Tukey’s multiple

comparison tests were performed on positive F values obtained from ANOVA to locate
significant differences.. Student’s t-tests were restricted to comparing reproductively
inhibited and similarly aged reproductively capable groups.
considered statistically significant.
Appendix C.

Data with p<0.05 were

Raw data and statistical analysis can be found in
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All work involving animal subjects has been approved by the Institutional Animal
Care and Use Committee, College o f William and Mary. All work involving infectious
agents and/or recombinant DNA has been approved by the Institutional Biosafety
Committee, College o f William and Mary. All work involving radioactive materials has
been approved by the Radiation Safety Officer, Department of Biology, College of
William and Mary.
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Results

Body, Reproductive Organ, and Adrenal Weights

The mean body, reproductive organ, and adrenal weights tended to increase with
age in control male animals at each of the four ages (30, 50, 70, and 90 days old, n=5 in
each age group) studied (Table 1). Mean paired testis mass o f 50 day control males was
significantly larger (p<0.05) than control males at 30 days of age (18.70 ± 1.99mg; 8.04 ±
1.51 mg, respectively).

Likewise, 90 day mean testis mass was significantly larger

(p<0.01) than control males at 70 days of age (36.74 ± 1.40mg; 23.12 ± 3.37mg,
respectively). Adrenal mass relative to body mass was not significantly different for any
age group.
Reproductively inhibited males had significantly smaller mean body mass (13.94
+ 0.96g; 18.89 ± 0.75g, respectively), adrenal mass (2.06 ± 0.12mg; 3.48 ± 0.45mg,
respectively), and testis mass (14.98 ± 1.94mg; 30.02 ± 2.70mg, respectively) than
reproductively capable control males of similar age (p<0.01, p<0.05, p<0.01
respectively). Seminal vesicle mass tended (p<0.1) to be lower in inhibited males than
similar aged controls (7.46 ± 1.74mg; 12.76 ± 3.10mg, respectively).

Adrenal mass

relative to body mass (mg adrenal mass per lOOg body mass) tended to be lower (p<0.1)
in inhibited males than similar aged controls (14.91 ± 0.88mg/100g; 18.28 ±
1.83mg/100g, respectively).
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Table 1 - Body, adrenal, and gonad weights o f control and inhibited male P. maniculatus o f different ages.
Values are presented as the mean (±SEM) for the total body, adrenal pair, testis pair, and seminal vesicle pair.
n=5 in each age category. Groups that are marked with different letters were significantly different at p<0.05
(maturation study and inhibition study are compared separately in this scheme).

Age
(days)

Body
Mass (g)

Adrenal
Mass (mg)

Testis
Mass (mg)

SemVes
Mass (mg)

Maturation Study
30

14.75 a
±1.19

2.94 a
±0.38

8.04 a
±1.51

4.33 a
±2.84

50

16.33 a
±0.98

3.38 a
±0.42

18.70 b
±1.99

5.84 a
±1.31

70

18.03 a
±0.57

3.70 a
±0.20

23.12 b
±3.37

11.50 a
±1.33

90

19.71 a
±0.87

4.26 a
±0.53

36.74 c
±1.40

15.28 a
±1.05

Inhibition Study

Control

18.89 a
±0.75

3.48 a
±0.45

30.02 a
±2.70

12.76 a
±3.10

Inhibited

13.94 b
±0.96

2.06 b
±0.12

14.98 b
±1.94

7.46 a
±1.74
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Maturation Study

Ribonuclease protection assays were performed to determine the expression
patterns o f hsd3bl and cypl 7 in the adrenals o f sexually maturing P. maniculatus, at time
points before (30 day), during (50 day), and after (70 and 90 day) the time of predicted
pubertal transition (n=5 per age group) (Figure 10a).

hsd3bl Expression
Like the ribosomal probe, the probe for hsd3bl also consistently protected two
closely migrating fragments, the 129bp fragment predicted from sequence analysis, and a
second fragment 2bp smaller.

To assure that a phenomena similar to the ribosomal

pattern was not overlooked, two hsd3bl expression analyses were performed; one
considering only the largest protected fragment, and a second including both protected
fragments. No significant differences were found between largest fragment analysis and
analysis including the second fragment. Data reported here include both fragments after
6 hours o f exposure to xray film with an intensifying screen at -80°C.
To determine total adrenal hsd3bl expression, hsd3bl signal was normalized with
the ribosomal internal control (expressed as the ratio hsd3bl / 18S ribosomal). The mean
values increase from the prepubertal (30d) to pubertal (50d) age group (1.236 to 1.784),
followed by mean values in adulthood that return to near prepubertal levels (1.372 at 70d;
1.314 at 90d). However, the range o f values for the hsd3bl expression at each of the ages
sampled are such that comparisons between the four age groups do not show any
significant differences (Figure 1 la).
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Figure 11 - Expression of adrenal hsdSbl in male P. maniculatus during normal maturation and in reproductive
inhibition, a) Mean expression o f adrenal hsd3bl increased during time o f expected pubertal transition, returning
approximately to prepubertal levels in adulthood, b) Mean adrenal hsd3bl expression was not significantly different in
reproductively inhibited males and similarly aged control males. Bar height represents mean with range bars included.
n=5 per group in both studies.
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pattern o f hsd3bl might be related to the degree of reproductive development.. In fact,
no statistically significant correlations were demonstrated between the body weight,
adrenal weight, or any gonad comparison with expression of hsd3bl (see Appendix C for
correlation analyses).

cypl 7 Expression
The probe for cypl 7 protected a single species of mRNA at 171bp, as expected
from sequence analysis.

Measurements for expression were taken after 2 weeks of

exposure to xray film with an intensifying screen at -80°C.
To determine total adrenal cypl 7 expression, cypl 7 signal was also normalized
using the ribosomal internal control (expressed as the ratio cypl 7 / 18S ribosomal). The
mean values increase from the prepubertal (30d) to pubertal (50d) age group (from 0.244
to 0.384), followed by mean values in adulthood that remain just above prepubertal levels
(0.354 at 70d; 0.288 at 90d). However, the mean values and the range of values for the
expression o f cypl 7 at each o f the ages sampled were such that comparisons between the
age groups do not show any significant differences (Figure 12a). To determine if the
expression pattern o f cypl 7 might be related to the amount of reproductive development,
correlation analyses o f the level o f gene expression versus the testes and seminal vesicle
weights were made and no correlations were demonstrated between the body weight,
adrenal weight, or any gonad comparison with expression o f cypl 7.
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cyp17 Expression by Age (Maturation Study)

cyp17 Expression by Age (Inhibition Study)

Control

inhibited

Figure 12 - Expression of adrenal cypl 7 in male P. maniculatus during normal maturation and in reproductive
inhibition, a) Mean expression o f adrenal cypl 7 increased during time o f expected pubertal transition, remaining
elevated above prepubertal levels into adulthood, b) Mean adrenal cypl 7 expression was significantly lower (p<0.01)
in reproductively inhibited males than in similarly aged control males. Bar height represents mean with range bars
included. n=5 per group in both studies.
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cypl 7 / hsd3bl Expression
The ratio o f the mean relative cypl 7 to hsd3bl expression at each age group tends
to increase from the prepubertal to pubertal age group (from 0.198 to 0.216), with a
continued increase at the postpubertal age of 70 days (0.242), and a subtle decline at 90
days o f age (0.220).

However, the range of values for the ratio o f cypl 7 / hsd3bl

expression at each o f the ages sampled are such that comparisons between the age groups
do not show any significant differences between age groups (Figure 13a). No significant
correlations were demonstrated between the body weight, adrenal weight, or any gonad
comparison with expression o f cypl7 / hsd3bl.

Reproductive Inhibition Study

Ribonuclease protection assays (RPAs) were also performed to determine the
expression patterns o f hsd3bl and cypl 7 in the adrenals of 130 (±10) day old
reproductively inhibited males, and 120 (±5) day old reproductively proven controls (n=5
per group) (Figure 10b).

Hsd3bl Expression
Although the mean hsd3bl expression in reproductively inhibited males is lower
than in similarly aged reproductively proven control males (1.203 and 1.557,
respectively) these mean values were not statistically significantly different (Figure 1 lb).
The range o f expression is from 1.05 to 2.67 in control animals, and from 0.82 to 2.04 in
reproductively inhibited animals.
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cyp17 / hsd3b1 Expression by Age Group (Maturation Study)
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Figure 13 - Expression o f adrenal cypl 7 / hsd3bl in male P. maniculatus during normal maturation and in reproductive
inhibition, a) Mean expression o f adrenal cypl 7 / hsd3bl increased throughout the maturational timecourse. b) Mean
adrenal cypl 7 / hsd3bl expression was significantly lower (p<0.01) in reproductively inhibited males than in similarly
aged control males. Bar height represents mean with range bars included. n=5 per group in both studies.
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The mean expression and range o f expression of control animals was most similar to the
values o f 70 day adult animals from the maturation study (mean - 1.372, range from 0.74
to 2.44).

The mean expression and range of expression o f reproductively inhibited

animals was similar to 90 day adult animals from the maturation study (mean - 1.314,
range from 0.89 to 1.99), as well as to the 30 day prepubertal age group from the
maturation study (mean - 1.237, range from 0.67 to 1.81).

A statistically significant

positive correlation between hsd3bl expression and seminal vesicle weight was found
(p<0.05), but not for body, adrenal, or testis weights.

Cypl 7 Expression
The mean cyp l7 expression expression value in reproductively inhibited males
was approximately one third that of the mean reproductively capable control male value
(0.111 and 0.345, respectively), a difference that was found to be statistically significant
(p<0.01) (Figure 12b). The cypl 7 mean expression value for the reproductively inhibited
animals was also significantly reduced when compared with each o f the age groups in the
maturation study (Figure 12a). The range of expression in inhibited animals was also
approximately half that o f similar aged controls (inhibited from 0.07 to 0.18; control from
0.28 to 0.52).

The mean expression and range o f expression o f control animals was

consistent with values o f 90 day adult animals from the maturation study (mean - 0.288,
range from 0.18 to 0.46). The mean expression and range of expression of inhibited
animals was different from all age group from the maturation study.

Statistically

significant positive correlations were found between cypl 7 expression and body, adrenal,
testis, and seminal vesicle weights (p<0.01, p<0.05, p<0.01, p<0.05, respectively).
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cypl 7 / hsdSbl Expression
The mean ratio o f cypl 7 / hsd3bl expression in reproductively inhibited males
was less than one half that of the corresponding mean ratio in reproductively capable
control male value (0.091 and 0.233, respectively), a difference that was found to be
statistically significant (p<0.005) (Figure 13b). This significant reduction in the mean
cypl 7 / hsd3bl expression ratio was also seen when comparing reproductively inhibited
animals with the corresponding ratios for 30, 50, 70, and 90 day males (p<0.01 for each,
from Figure 13a). The range o f expression in inhibited animals was also approximately
half that o f similar aged controls (inhibited from 0.08 to 0.12; control from 0.19 to 0.29).
The mean expression and range of expression of control animals was consistent with
values o f 90 day adult animals from the maturation study (mean - 0.221, range from 0.15
to 0.28). The lower mean expression and range of expression of inhibited animals was
significantly different from all other age groups in the maturation study.

Statistically

significant correlations were found between cypl 7 / hsd3bl expression ratio and the
body, adrenal, and testis weights (p<0.01, p<0.05, p<0.01, respectively).

Mass Approximation

A separate RPA was conducted to estimate the mass of the expressed mRNA for
cypl 7 and hsd3bl. This assay relates the optical density measured for known masses of a
sense sequence hybridized with excess antisense probe to experimental hybridization
reactions. The mass o f the protected fragment of the sense sequence was the same as the
mass o f the antisense probe after digestion; 171 bp for cypl 7 and 129bp for hsd3bl. The
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full length cDNA for cypl 7 is reported to be 1724bp in hamster (Cloutier et al., 1996)
and the full length cDNA for hsd3bl is reported to be 1119bp for mouse (Payne et al.,
1997). The percentage differences between the sizes o f the probes and the sizes o f the
full length mRNA were 10.1% for cypl 7 and 11.5% for hsb3bl. Therefore, the estimated
masses were corrected by these factors, as well as for RNA loss through the ribosomal
RNA internal control as described above. The cypl 7 mRNA was estimated to be as low
as 7.9pg in inhibited animals, and as high as 61.4pg in control animals. The estimated
mass o f the hsd3bl mRNA was estimated to be as low as 523pg in prepubertal (30d)
animals, and as high as 2080pg in pubertal (50d) animals.
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Discussion

Maturation Study
The presence o f 3PHSD is obligate to the production of all biologically active
adrenal

steroids

including

the

essential

mineralcorticoid

aldosterone,

and the

glucocorticoid corticosterone (Wilson, 1998). As expected, hsd3bl was expressed in the
adrenals o f all animals in this study (Figure 11). The mean value for the expression of
hsd3bl at each o f the four ages evaluated showed a non-significant increase at 50 days
and then returned to prepubertal levels by 70 and 90 days (Figure 11a). The rise in
hsd3bl expression during the expected time of puberty (50 days) demonstrates that
hsd3bl expression is not necessarily a function of increasing adrenal size because the
adrenals continue to increased in mass at 70 and 90 days without increasing hsd3bl
expression. Furthermore, the ratio of adrenal mass relative to body mass does not change
significantly at any o f the ages studied (Table 1). Taken together, this increase in hsd3bl
expression at 50 days suggest that overall adrenal steroid activity is slightly elevated
during the pubertal transition.
The expression o f cypl 7 is not required for the production o f the critical rodent
hormones corticosterone and aldosterone. However, if cortisol or weak androgens are
made the enzyme must be present.

Unlike 3pHSD, cy p l7 has not been previously

reported in the adrenal o f any Peromyscus species.

This present study can not

differentiate between the possible products of cypl7 action. Because the cypl7 enzyme
catalyzes both 17a-hydroxylase and 17,20-lyase activities, its presence may lead to the
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production o f either cortisol and/or weak androgens, depending upon the presence and
activity o f P450 oxidative reductase (OR) (Cloutier et al., 1997; Miller et al., 1998).
We have radioimmunoassay data from our laboratory indicating that low serum
concentrations o f both cortisol and the weak androgen DHEA exist in P. maniculatus
(Cherry, 2001), although it is not possible to determine whether these steroids are of
adrenal or gonadal origin. Our present report of low levels of cypl 7 expression in the
adrenals o f all age groups (Figure 12), suggests that the adrenal is at least contributing to
some o f the observed serum cortisol and/or DHEA.
The pattern o f cypl 7 expression generally was similar to hsd3bl throughout
pubertal development, with a modest and transient increase in mean expression at the
time o f puberty (50 days), followed by a return to prepubertal levels at 70 and 90 days
(Figure 12a). These data suggest that there may be some increase in weak androgen
and/or cortisol production during puberty. However, the lack of a statistically significant
increase in either hsdSbl and/or cypl 7 expression in this maturation study suggests that
there is likely no adrenarche-like event linked with pubertal transition equivalent to the
condition reported in humans (Remer and Manz, 1999; Miller, 1999).
The enzyme 3pHSD has been shown to compete with cypl7 for the substrate
pregnenolone (Gell et al., 1998). This observation prompted our examination of the ratio
o f cypl 7 to hsd3bl at each o f the four age groupings to elucidate whether the pathway
leading to the weak androgens and cortisol may be increased over the production of
adrenal glucocorticoids and mineralcorticoids.

Although no statistically significant

changes were found between these ratios for any age grouping, some increase in the
mean ratio was seen during pubertal development, which peaked at 70 days before a
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subtle decline at 90 days of age. This small change suggests an increase in the adrenal
production o f cypl 7-dependant hormones during the pubertal transition, however the lack
of statistically significant differences between the four age groups seems to argue against
a major effect o f the adrenal in the pubertal transition.
The wide range in the levels o f hsd3bl and cypl 7 expression within each age
grouping prompted a consideration of whether the range of expression might reflect a
lack of strict correlation o f expression with chronological age. Indeed, the ranges in testis
and seminal vesicle mass in each age group supports the notion that chronological age is
not a strict indicator o f developmental age. Positive relationships between the increased
expression o f either hsd3bl or cypl 7, and both the testis and the seminal vesicle mass,
were found when all o f the maturational age group data were combined in a single
regression analysis.

However, none of these analyses were shown to be statistically

significantly correlated.

This suggests that during normal maturation at the ages

evaluated there is not a strict dependence on the size of the testes or the seminal vesicles
with adrenal steroid activity. Clearly then other factors are likely to also influence this
relationship. It is likely that the range of expression values observed at each age reflects,
among other things, the varying frequency of the release of aldosterone and
corticosterone in response to changes in activities such as feeding, drinking, and response
to stress. It is therefore reasonable to expect that expression of hsd3bl and cypl 7 will
change throughout the day. Although we collected all adrenals during a set period of the
inactive/ sleep cycle, it is possible that this 2-3 hour collection period could include a
range o f physiological conditions requiring different levels of adrenal activity that would
not be related to sexual maturatin, per se.
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An additional complication may result from the likelihood that animals start a
pubertal transition at different chronological ages. Hence, sampling adrenal tissue at only
30 and 50 days old will condense the continuum of gonad maturation stages into only two
groups making the possibility of detecting transient adrenal-gonad changes more
difficult.

Inhibition Study
As in previous studies o f P. maniculatus (Terman, 1973b; Bradley and Terman,
1981a,b,c), reproductively inhibited animals in this study exhibited body, gonad, and
adrenal masses that were all significantly smaller than similarly aged reproductively
capable controls (Table 1). When compared with these earlier studies o f organ mass and
histology, as well as hormone profiles, these data suggest that the animals selected from
laboratory populations in this study are indeed reproductively inhibited, even at an age
approximately three times the normal age o f the pubertal transition.
Although the masses o f adrenals from reproductively inhibited animals were
statistically significantly less than controls (Table 1), the reduction in hsd3bl expression
was not statistically significantly different from the control value. This suggests that the
adrenals o f reproductively inhibited animals are not different from similarly aged controls
in terms o f their ability to produce corticosterone and aldosterone (Figure lib ).
However, the mean value for the expression o f cypl 7 was statistically significantly lower
in reproductively inhibited animals compared with controls of similar age (Figure 12b),
as well as every other mean expression value for each o f the age groups in the maturation
study (Figure 12a).

These findings indicate a disruption in cypl 7 expression in
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reproductively inhibited animals that is not seen even in the 30 day prepubertal group
which have small adrenal masses that are not different from inhibited animals.

In

addition, the statistically significant positive correlations found between cypl 7 expression
and reproductive organ masses within the group of inhibited males suggests some role for
adrenal cypl 7 in reproductive inhibition.
Based on the statistically significant reduction o f cypl 7 expression in
reproductively inhibited animals compared with all other groups, it was not unexpected to
find a similar statistically significant reduction in the cypl 7 / hsdSbl expression ratio
(Figure 13b).

This reduction indicates that there is likely to be an altered pattern of

hormone production in reproductively inhibited animals compared to similarly aged
normally maturing .animals. Although statistically significantly lower than for all age
groups from the maturation study, the cypl 7 / hsd3bl expression value of reproductively
inhibited animals most closely approximated the low values seen in 30 day immature
animals. These data indicate that reproductive inhibition involves a drastic reduction in
the production o f either cortisol and/or weak androgens, but not in the mineralcorticoid or
glucocorticoid production levels.
It is clear from this study that reproductive inhibition involves a drastic reduction
in adrenal cypl 7 expression in Peromyscus.

What is not clear is whether the adrenal

changes contribute directly to the pubertal transition as they may in human adrenarche
when adrenal androgen production increases dramatically (Miller, 1999). This study was
not designed to differentiate between the production o f cortisol versus weak androgens
that might be produced by the dual enzymatic activities o f cypl7.

It may be that

increased cypl 7 expression at puberty is related to developmental factors that are more
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basic than sexual maturation per se. If general metabolic changes must occur prior to or
concomitant with puberty, then there may be an increased need for the minor
glucocorticoid cortisol. Alternatively, an increase in adrenal weak androgens could be
important to processes that are not directly related to gonadal maturation. Such is the
case in humans, where adrenal androgens are known to contribute to secondary sex
characteristics such as pubic hair growth (Wilson et al., 1998). Additional studies will be
necessary to determine which o f Has-cypl 7-dependent hormone products is actually being
produced before these questions can be answered.
The finding in this study that the hsd3bl expression in reproductively inhibited
animals is not significantly different from controls indicates that there may be no large
differences in the levels o f production of corticosterone (or aldosterone).

This

observation should be considered relative to several earlier reports finding serum
r

corticosterone to be significantly elevated in reproductively inhibited animals, despite the
fact that these animals show no gravimetric evidence of adrenal hypertrophy (Sung et al.,
1977; Bradley and Terman, 1981c; Ransone and Bradley, 1992). To resolve this apparent
paradox o f elevated hormone levels without adrenal hypertrophy, it was earlier suggested
that the elevations in serum corticosterone concentration may not be due to stresselevated pituitary activation o f the adrenal, but rather due to either an increase in
protective serum protein binding and/or a reduction in the metabolic clearance rate of the
steroid (Bradley and Terman, 1981c). The present findings add cosiderable support to
this explanation.
The adrenal zonal distribution o f cypl 7 in P. maniculatus is currently unknown.
The mRNA and enzyme have been found in the zona fasciculata in hamster (Briere et al.,
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1997), in the zonae fasciculata and reticularis in the guinea pig (Shinzawa et al., 1988;
Tremblay et al., 1994), and in the zonae fasciculata and reticularis in primates (Mapes et
al., 1999).

The significant reduction in cypl 7 expression by reproductively inhibited

animals coincides with the significant increase in small, presumably dysfunctional,
pycnotic cells in the zona reticularis o f reproductively inhibited P. maniculatus reported
by Cherry (1998), suggesting that the zona reticularis is, at least in part, responsible for
expression o f cypl 7 in normal P. maniculatus.
In summary, the finding of no significant differences in the adrenal expression of
hsd3bl between reproductively inhibited animals and controls indicates that these
adrenals from inhibited animals are not compromised with respect to the production of
corticosterone and aldosterone, but produce far less of the cypl 7-dependent additional
hormones characteristic o f normally maturing animals over 30 days of age. Whether
these weak androgens and/or cortisol are responsible for, or the consequence of, the
pubertal transition is not presently known, but these data clearly support an association of
changes in adrenal cypl 7 activity with pubertal transition.
A future study sampling animals at a larger number o f time points around the
expected time o f puberty might elucidate more transient increases in hsd3bl and/or cypl 7
expression to ensure that a critical period of significantly altered mRNA production is not
overlooked.

In addition, to determine temporal-spatial distribution of the enzymes

encoded by these genes, antibodies against cypl7 and 3pHSD should be used in
immunohistochemical investigations.

Also, the simultaneous study o f the serum

concentrations o f cortisol and corticosterone through RIA should be employed to
determine if cortisol is more than a minor glucocorticoid in Peromyscus species. To
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expand on previous RIA results indicating the presence of DHEA (Cherry, 2001),
additional assays should be performed to determine if additional C19 steroids are being
made by the low levels o f cypl 7 expression discovered in this study.

Such future

investigations would help to further clarify the potential influence(s) o f the changing
expression levels o f hsd3bl and cypl 7 in normally maturing and reproductively inhibited
P. maniculatus presented by this study.
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Appendix A - Sequences & Alignments

Clone Sequences

Hsd3bl (Murine Type I, Portion of Exon 3)

TAGTGTGTTC

ACCTTCTCCT

ACAAGAAAGC

TCAGCGAGGT

CTGGGCTATG

AGCACCTATC

AGCTGGGAGG

AAGCCAGACA

GAAAACTTCA

CAGTGGATTG

GGTCACTAGT

GGAGCAGCAC

AAGGAGACA

40
80

120

129

Cypl 7 (5’ Upstream Sequence and Portion of Exon 1)

40

a a g a g a ta a c

a c a a c ttc a a

g g tg a c a a c c

agggaggcct

ttta a a a g tc

c c c c ttc tc c

g tta g a g tc g

ctg a g cctct

c CACGCTGGC

CATCTGCTGA

CACCTGGCTA

CCATGTGGGA

ACTCGTGTGT

CTCTTGCTGC

TCATCCTAGC

CTTTCTCTTT

160

TGGCCCAAGC

CAAAGACATT

TGATGCCAAG

TTTCCCAGGA

200

GCCTCCCATT

CCTGCCCCTT

GTGGGCAGCC

TGCCGTTTCT

240

CCCCAGACAC

GG

252

*lower case indicates 5’ upstream sequence
*underline indicates 5’UTR
*bold faced bases indicate start site o f translation (CDS)

80
120

79

PTRIRNA 18S (Ambion; Austin, TX)

TCCCAAGATC

CAACTACGAG

CTTTTTAACT

GCAGCAACTT

40

TAATATACGC

TATTGGAGCT

GGAATTACCG

CGGCTGCTGT

80

TCAGGTTGTC

TCCAGCGACT

TCAACAGTGA

CCCCCACTCT

40

TCCACCTTCG

ATGCTGGGGC

TGGAATTGCC

CTCAATGACA

80

GCTGACCCCT

TATTCTGTTT

CAACTCCAGT

GGCAAAGTAC

CTAAAAACCA

ACATGGTGAC

CAAGACTGCC

GATGAGTTTG

TTAAAGAGTC

CTTGAAATAT

ATCACGATCG

GAGCTGAAAC

CTGTGGCTGC

CTTGCTCATG

AAATC

GAPD

17J3KSR Clone

145

40
80

120

80

Hsd3bl Alignment (Rodents Type I, Human Type II)

P. maniculatus

TGTCTCCTTGTGCTGCTCCACTAGTGACCCAATCCACTGTGAAGT 45

R. norvegicus

H. sapiens

--------------- C ----------------------------------------- T ------ G---------------- CC
G---G -------------------------------- O G ------------- A -----G ----- A ---------- C -------------- CCACG —

p. maniculatus

TTTCTGTCTGGCTTCCTCCCAGCTGACAGGTGCTCATAGCCCAGA 90

H. sapiens

------------- C T---------------------------------------- TA — TG------ T

P. maniculatus
M. auratus

CCTCGCTGAGCTTTCTTGTAGGAGAAGGTGAACACACTA 129
T ----------------------------------------------------------------------------------------

H. sapiens

-------------------------C------------------ A -----------------------------------------

CG----------

GAPD Alignment

p . maniculatus

TCAGGTTGTCTCCAGCGACTTCAACAGTGACCCCCACTCTTCCAC 45

R. norvegicus

------------------------------ T —T ------------------------- CA---- T ---------T ------------------

H.

C -------------- G ----------------- T C T -------------------------------- C -------- A -------------------- C --------------

sapiens

CTTCGATGCTGGGGCTGGAATTGCCCTCAATGACA 80
T ---------------------------------C------------T ---------------------musculus
-------------------- C------------------ C-----------T ----------------------norvegicus
T ---------------------------------C ------------T ---------------------sapiens
T---- C --------------------------C
C
C

P. m a n i c u l a t u s
M. auratus
M.
R.
H.

81

C ypl 7 Alignm ent (Portion of Exon 1)

CACGCTGGCCATCTGCTGACACCTGGCTACCATGTGGGAACTCGT
GCA
G------------------------------/ / / / / / / T ~ G ------------------------------ T ---ACA-----------------------------C T ------------------------ G-----------------------------T —
ACA-----------------------------C T ------------------------ G-----------------------------T
ACT
T ~T
/ / / / / / / / / / / G~ C ------------------------- G-----------

45

90

R. norvegicus

GTGTCTCTTGCTGCTCATCCTAGCCTTTCTCTTTTGGCCCAAGCC
~G C
C -------------------- C ------ G
A -'T ------------------ T ----------- T ~
------------------------------------------------ G----------A - T -------------------------------T ~G ------------------------------------------------------- A ~ T ------------------ GT-------- T —

H. sapiens

"G C --------------------------- T - C --------------T - A - T - G --------------------------- AG

P. maniculatus

AAAGACATTTGATGCCAAGTTTCCCAGGAGCCTCCCATTCCTGCC
------------- G—G----G------------------ CG---------A ------------------------------------------

P. maniculatus
M. auratus
M. musculus
R. norvegicus
H. sapiens

P. maniculatus
M. auratus
M. musculus

M. auratus

R. norvegicus
H. sapiens

P. maniculatus

135

------------- GCCC~G----------------C ~ C ------------------------- T --------- C------------— G -T G C C C — G------------------- A C -------- A ------------------- T G -C ------------

CCTTGTGGGCAGCCTGCCGTTTCTCCCCAGACACGG

M. a u r a t u s

G---------------------------------------------- —A ------------------------------

M. musculus

G-----------T ----T ---- A ----------------------------------------------

171

*Boldfa ced bases indicate start site o f CDS, underline indicates 5 ’UTR
*Full clone also includes 81 bp o f 5 ’ upstream sequence, not included in this alignment
(252bp total length with 5 ’upstream sequence included)
*Hash marks indicate significant divergence of sequence (ie. missing or additional bases)
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Appendix B - Protocols

RPA Protocol

Updated 2-13-01 BL

A. Probe synthesis

1- set up transcription rxn
@ rm temp:

*behind shield from here on->

4.0|ul 5x transcription buffer
l.OjLtl sddH20
2.0jul lOOmMDTT
4.0pl r(CAG)TP Mix
lOjal each o f lOmM rATP,
2 .4 jll1 lOOpM UTP carrier
rCTP, rGTP +10^1 sddH20
2.0pl linearized DNA template
0.6pl RNase Block (RNasin)
3.0pl 32P-aUTP (800ci/mmol)
1.Op.1 appropriate RNA polymerase (T3/T7/SP6)

2- flick mix, pulse spin down, and incubate @ 37°C (behind shield) for 90 minutes (see #4)
3- make & pour 6% polyacrylamide gel (see recipe page) using inch long spacers to make wells
(use more spacers than necessary - wells sometimes break when pulling spacers out)
4- after first 40 min of transcription rxn, add an additional 0 . 5 j l l 1 RNA polymerase to increase
yield (doping)
5- add 1-Ojul DNase, flick mix, incubate for 15 more minutes @ 37°C
6- prepare gel for running - make 2L 0.5x TBE, assemble apparatus, clean wells
7- add lOjul RPA-formamide dye to rxns, boil 3 min to denature, place on ice, load all
8- run gel @ 2000v (normal setting) for about 40-50 min (fast dye —2/3 from top)
9- turn on 65°C water bath for upcoming elution

B. Probe Purification

1- carry plate to darkroom, separate with licor wedge, and cover gel with saran wrap (hold upper
plate between you and gel for radio protection - may want to work behind shield if many
probes)
2- turn off lights and place film atop saran wrap and below upper plate, add some weight to top
plate and expose for 2 minutes (be sure to place film in an orientation that you will not forget!)
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3- develop film - 2 min developer, 30 sec water, 3 min fixer, 30 sec water
4- lights on - place film on bench and place plates on top using alignment from previous exposure
(#2)
5- slide top plate off first band, pull saran back, and excise band with razor blades wiped with
DEPC H20 soaked kim wipe and place in epp containing 400pl elution buffer (be sure band is
immersed —also - remember ALARA)
6- elute in 65°C water bath for 3-4 hours
7- after elution, transfer eluates but not gels to new epps and remove 1pi to count with scinti (spin
gel to bottom briefly - allows easier eluate removal, and allows liquid to cool - more accurate
ljul this way)
8- add 1ml 100% EtOH to each epp and precip @ -80°C for > 30 min —turn H20 bath to 50°C
9- spin @ +4°C for 20 minutes (max), remove super to radio waste -- turn heat block to 85°C
10- resuspend pellets .in an amount of hyb that will approximately get you 50k cpm/ pi (ex. if
you had 100k cpmI pi before, use 800pl hyb - doubling previous 400pl and therefore halving
per pi count)
11- remove another lpl and count in scinti

C. Hybridization Rxns

1- thaw RNA on ice
2- label epps for each hyb and aliquot xpl RNA to each (check with ELB/ MSS for RNA mass &
volume you should use)
3- dry down RNA in speedvac (but don’t overdry - want them just dry -5-20 minutes usually)
4- each hyb rxn will be 20pl total volume - want to add ~50k cpm of each probe, and enough hyb
for 20pl total volume (use scinti counts to determine volume necessary to achieve 50k)
5- add hyb first, then add probes (hyb first will allow pellet to begin going into solution and make
adding small volumes easier)
6- flick mix, pulse spin down, and denature @ 85°C for 10 minutes, transfer immediately to 50°C
water bath (take entire heat block to water bath and transfer directly)
7- hyb for at least 10 hours
--------------------- end day I ------------------------
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D. Digestion Rxns

1- make digestion mix (just enough - see #2 - expensive RNases!)
10 mM Tris
5 mM EDTA
300 mM NaCl
sddH20
2pg/ml RNase T1
40pg/ml RNase A

ex. 5mls ->

50pl 1M Tris
50pl 0.5M EDTA
300pl 5M NaCl
4392pl sddH20
8jnl RNase T1
200jitl RNase A

*RNases used only in hood - be excessively careful

2- set heat block to 50°C -- transfer epps to this heat block and add 350pl digestion mix to each
epp (in hood, and still in heat block -- this assures RNase digestion at prescribed stringency)
3- flick mix and transfer to 37°C block (also in hood) for 30 minutes —thaw Proteinase K &
tRNA on ice
4- make and pour 6% polyacrylamide gel using large sharkstoothe comb (red) inverted to form
well
5- stop digestion by adding 20pi 10% SDS followed by lOpl Proteinase K (5mg/ml), flick mix
and incubate an additional 15 min @ 37°C
6- add 400pl P/C, vortex 3 sec, place on ice, then spin for 10 min @ +4°C (12k rpm)
7- during spin, add 2.7pl (9.8mg/ml) tRNA to new epps, transfer aq to these new tubes
8- flick mix well, then add 1ml Ab EtOH to each epp & precip @ -80°C for > 30 min
9- spin 20 min @ max in +4°C, remove & discard supers by pouring into radio waste & speedvac
just dry

E. Running Samples

1- resuspend samples in 2pl TE @ rm temp - and prepare gel for running (assemble, clean wells,
insert cleaned comb, make 0.5x TBE, begin prerunning gel)
2- add 2 pi RPA-formamide dye to samples -- begin boiling water
3- prepare ‘probe only’ samples -- 2pl probe + 4pl RPA-form dye —also, get ladders out
4- place samples in nalgene plastic racks in desired loading order and boil 3 min, place on ice
5- after about 1 min ice time, pulse spin samples down and load

85

6- run gel so that slow dye front is approximately 8 inches from well bottom (1:45 - 2:30 total)
7- separate plates with licor wedge (carefully) and apply 3MM paper (take a good minute to
assure gel is firmly attached to paper) peel up, cover with saran, and gel dry @ 78°C for 2- 2
V2 hours
8- remove saran, and in dark room, add to cassette - gel, film, intensifying screen (reflective side
towards film) and place in -80°C for 6 hrs - 2 wks depending on expression (ask ELB/ MSS for
advice)
-----------end------------see next page for RPA solution recipes

86

RPA Recipes

Hybridization Buffer
(4 m ls)

3 3 5 0 jll1 deionized

formamide
5M NaCL
3 2 0 p l 0.5M PIPES
8jul 0.5M EDTA
320jLtl

store @ +4°C (make fresh each RPA)

Elution Buffer
(lOmls)

83 13j l x 1 sddH20
lOOOpl 10% SDS
667pl 7.5M NH4Ac
20pl 0.5M EDTA

store @ +4°C

RPA-Formamide Loading Dye
(lm l)

800jiil deionized formamide
20pl 0.5M EDTA
90pl xylene cyanol (lOmg/ml)
90pl bromophenol blue (lOmg/ml)

store @ +4°C

6% Polyacrylamide Gel
46.Og urea
40ml sddH20
15ml 40% polyacrylamide
5ml lOxTBE
1- stir on lowest heat (turn heat off after a few minutes of stirring) with foil covering top of
beaker
2- prepare 10% APS (lm l sddH20 + lOmg APS) (often aliquotted in -20°C)
3 - add 700pl 10% APS & 18 jlx1 TEMED, stir for additional 20 sec and pour gel
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RPA Im age Analysis Procedure

Used by BLovitt - Outlined Feb 23, 2001

* The following protocol was developed using Im ageJ (v.2.1) with SpecifiRO I plugin - both
downloadable @ http://rsb.info.nih.gov/ij/ SpecifiROI saved into ‘ImageJ plug-ins’ folder on
hard drive
* ImageJ is public image analysis software, and SpecifiROI is a plugin that allows you to specify
a ROIs pixel dimensions.

1- Film scanned into ELBs computer as black & white ‘image only’
2- After preview was generated, resolution was changed to 600dpi, and ‘perform rescan if
necessary’ box was checked.
3- A region of interest was drawn to exclude nonessential parts of the film, and the ‘OK’ button
was checked - this brings up the ‘save as’ dialog box - save pictures as ‘noncompressed tiffs’
4- These files are very large (>30mb possibly), and ImageJ may have trouble opening them/
working efficiently with them, so I used Photoshop 5.0 (any image analysis program will
work) to crop the film into three pictures - corresponding to the areas of my probes (ie. first
crop contains all ribosomal bands, with an inch above and below bands in crop; second & third
containing second and third probes with appropriate room above and below)
a- to keep track of cropped images, I used the typing tool in Photoshop to label the pictures
directly (in a corner out o f the way) and saved them with appropriate corresponding filename
5- Using ImageJ, open the crop that corresponds to the control bands (ribo for mine)
6- Use the magnifying glass to enlarge to preference (may have to enlarge window by dragging
on comer after magnifying)

7- Click on rectangle tool on ImageJ main window.
8- Select ‘plug-ins’ - ‘utilities’ - ‘panel’ the SpecifiROI window will appear
9- On opened image, draw a rectangle slightly larger than largest band of interest, then click on
‘specify ROI’ button of newly opened ‘panel’ - the pixel dimensions of your rectangle will be
shown. This allows you to manipulate the rectangle size (by entering new values) or record the
pixel dimension you intend to use for every other similar band (ie. same gene)
10- Once you have chosen a dimension, you can fine tune the position of the rectangle by
dragging it, or using the keyboards arrows.
11- When positioned correctly, chose ‘analyze’ - ‘histogram’ and a histogram of the pixels
luminescence within the ROI will appear - record the ‘mean’.
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12- Move the ROI onto an immediately adjacent area of the film that represents the background
(ie. no exposure showing) and repeat ‘histogram’ function - recording again the ‘mean’
13- Subtracting the control bands mean from the background mean will give you the ‘darkness’
or ‘expression’ of the band corrected for background.
14-1 then repeated this same procedure for every hybridization on the films crop.
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Appendix C - Data & Statistical Analyses

Statistical Analyses

One way analysis o f variance (ANOVA), Tukey’s multiple pairwise comparison, and
paired t-test performed using StatsDirect Statistical Software v. 1.9.0
(copyright 3/1/2001).

Available @ http://www.statsdirect.com
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Maturation Study - Body Mass by Age

One wav analysis of variance

Variables: 30, 50, 70, 90 day control male P. maniculatus

Source of Variation

Sum Squares

DF

Mean Square

Between Groups

68.7415

3

22.913833

Within Groups

68.8669

16

4.30418

Corrected Total

137.6084

19

F (variance ratio) = 5.323623

P = 0.0098

Tukev multiple comparisons

Critical value (Studentized range) = 4.046093, |q*| = 2.861082
Pooled standard deviation = 2.074652

Comparison Mean Difference L (95% Cl)

|L/SE(L)|

30 vs 90

-4.96 (-8.71 t o -1.20)

5.34

P=0.008

50 vs 90

-3.38 (-7.13 to 0.37)

3.64

P=0.085

30 vs 70

-3.28 (-7.03 to 0.47)

3.54

P=0.098

50 vs 70

-1.7 (-5.45 to 2.05)

1.83

P=0.579

70 vs 90

-1.68 (-5.43 to 2.07)

1.81

P=0.588

30 vs 50

-1.58 (-5.33 to 2.17)

1.70

P=0.633
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Maturation Study - Adrenal (Pair) Mass by Age

One wav analysis of variance

Variables: 30, 50, 70, 90 day control male P. maniculatus

Source o f Variation

Sum Squares

DF

Between Groups

4.63

3

1.543333

Within Groups

12.792

16

0.7995

Corrected Total

17.422

19

F (variance ratio) = 1.930373

Mean Square

P = 0.1654

Tukev multiple comparisons

Critical value (Studentized range) = 4.046093, |q*| = 2.861082
Pooled standard deviation = 0.894148

C om parison M ean Difference L (95% C l)

|L/SE(L)|

30 vs 90

-1.32 (-2.93 to 0.29)

3.30

P=0.131

50 vs 90

-0.88 (-2.50 to 0.74)

2.20

P=0.430

30 vs 70

-0.76 (-2.38 to 0.86)

1.90

P=0.55

70 vs 90

-0.56 (-2.18 to 1.06)

1.40

P=0.757

30 vs 50

-0.44 (-2.06 to 1.18)

1.10

P=0.863

50 vs 70

-0.32 (-1.94 to 1.30)

0.80

P=0.941
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Maturation Study - Testis (Pair) Mass by Age

One wav analysis of variance

Variables: 30, 50, 70, 90 day control male P. maniculatus

Source o f Variation

Sum Squares

DF

Mean Square

Between Groups

2119.018

3

706.339333

Within Groups

391.532

16

24.47075

Corrected Total

2510.55

19

F (variance ratio) = 28.864638

P < 0.0001

Tukev multiple comparisons

Critical value (Studentized range) = 4.046093, |q*| = 2.861082
Pooled standard deviation = 4.946792

Comparison Mean Difference L (95% Cl)

|L/SE(L)|

30 vs 90

-28.7 (-37.65 t o -19.75)

12.97

P 0 .0 0 0 1

50 vs 90

-18.04 (-26.99 t o -9.09)

8.15

P=0.0002

30 vs 70

-15.08 (-24.03 to -6.13)

6.82

P=0.001

70 vs 90

-13.62 (-22.57 to -4.67)

6.16

P=0.0025

30 vs 50

-10.66 (-19.61 t o -1.71)

4.82

P=0.017

50 vs 70

-4.42 (-13.37 to 4.53)

2.00

P=0.509
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Maturation Study - Seminal Vesicle (Pair) Mass by Age

One w av analysis of variance

Variables: 30, 50, 70, 90 day control male P. maniculatus

Source o f Variation

Sum Squares

DF

Between Groups

329.538039

3

109.846013

Within Groups

125.746667

16

9.672821

Corrected Total

455.284706

19

F (variance ratio) = 11.356151

Mean Square

P = 0.0006

Tukev m ultiple com parisons

Critical value (Studentized range) = 4.150866, |q*| = 2.935169
Pooled standard deviation = 3.110116

Com parison M ean Difference L (95% C l)

|L/SE(L)|

30 vs 90

-10.95 (-17.61 to -4.28)

6.81

P=0.0017

50 vs 90

-9.44 (-15.21 to -3.67)

6.79

P=0.0017

30 vs 70

-7.17 (-14.14 to -0.19)

4.27

P=0.0432

50 vs 70

-5.66 (-11.78 to 0.46)

3.84

P=0.074

70 vs 90

-3.78 (-9.90 to 2.34)

2.56

P=0.3115

30 vs 50

-1.51 (-8.17 to 5.16)

0.94

P=0.9089
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Inhibition Study - Body Mass

Paired t test

For differences between control and inhibited:
Mean o f differences = 4.948
Standard deviation = 2.498794
Standard error = 1.117495

95% Cl = 1.845338 to 8.050662

df = 4
t = 4.427762

One sided P = 0.0057
Two sided P = 0.0114
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Inhibition Study - Adrenal (Pair) Mass

Paired t test

For differences between control and inhibited:
Mean o f differences = 1.42
Standard deviation = 1.241773
Standard error = 0.555338

95% Cl = -0.121865 to 2.961865

df = 4
t = 2.557003

One sided P = 0.0314
Two sided P = 0.0628
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Inhibition Study - Testis (Pair) Mass

Paired t test

For differences between control and inhibited:
Mean o f differences =15.04
Standard deviation = 7.376517
Standard error = 3.298879

95% Cl = 5.880845 to 24.199155

d f= 4
t = 4.559125

One sided P = 0.0052
Two sided P = 0.0103
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Inhibition Study - Seminal Vesicle (Pair) Mass

Paired t test

For differences between control and inhibited:
Mean o f differences = 5.3
Standard deviation = 8.555992
Standard error = 3.826356

95% Cl = -5.323667 to 15.923667

df = 4
t = 1.38513

One sided P = 0.1191
Two sided P = 0.2383
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Maturation Study - Hsd3bl Expression by Age

One wav analysis of variance

Variables: 30, 50, 70, 90 day control male P. maniculatus

Source o f Variation

Sum Sauares

DF

Mean Sauare

Between Groups

0.8888

3

0.296267

Within Groups

5.51348

16

0.344593

Corrected Total

6.40228

19

F (variance ratio) = 0.859759

P = 0.48197

Tukev multiple comparisons

Critical value (Studentized range) = 4.046093, |q*| = 2.861082
Pooled standard deviation = 0.58702

Comparison Mean Difference L (95% Cl)

|L/SE(L)|

30 vs 50

-0.544 (-1.61 to 0.52)

2.07

P=0.4798

50 vs 90

0.468 (-0.59 to 1.53)

1.78

P=0.5995

50 vs 70

0.412 (-0.65 to 1.47)

1.57

P=0.6889

30 vs 70

-0.132 (-1.19 to 0.93)

0.50

P=0.984

30 vs 90

-0.076 (-1.13 to 0.99)

0.29

P=0.9968

70 vs 90

0.056 (-1.01 to 1.12)

0.21

P=0.9987
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Maturation Study - Cypl 7 Expression by Age

One wav analysis of variance

Variables: 30, 50, 70, 90 day control male P. maniculatus

Source of Variation

Sum Squares

DF

Mean Square

Between Groups

0.057535

3

0.019178

Within Groups

0.50632

16

0.031645

Corrected Total

0.563855

19

F (variance ratio) = 0.606046

P = 0.620603

Tukev multiple comparisons

Critical value (Studentized range) = 4.046093, |q*| = 2.861082
Pooled standard deviation = 0.17789

Comparison Mean Difference L (95% Cl)

|L/SE(L)|

30 vs 50

-0.136 (-0.46 to 0.19)

1.71

P=0.6303

50 vs 70

-0.11 (-0.43 to 0.21)

1.38

P=0.7638

50 vs 90

0.092 (-0.23 to 0.41)

1.15

P=0.8452

70 vs 90

0.066 (-0.26 to 0.39)

0.83

P=0.9347

30 vs 90

-0.044 (-0.37 to 0.28)

0.55

P=0.979

50 vs 70

0.026 (-0.30 to 0.35)

0.33

P=0.9955
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Maturation Study - Cypl7/ Hsd3bl Expression by Age

One wav analysis of variance

Variables: 30, 50, 70, 90 day control male P. maniculatus

Source o f Variation

Sum Squares

DF

Mean Square

Between Groups

0.004935

3

0.001645

Within Groups

0.04844

16

0.003028

Corrected Total

0.053375

19

F (variance ratio) = 0.543353

P = 0.659581

Tukev m ultiple com parisons

Critical value (Studentized range) = 4.046093, |q*| = 2.861082
Pooled standard deviation = 0.055023

Com parison M ean Difference L (95% C l)

|L/SE(L)|

30 vs 70

-0.044 (-0.14 to 0.06)

1.79

P=0.5972

50 vs 70

-0.026 (-0.13 to 0.07)

1.06

P=0.8765

30 vs 90

-0.024 (-0.12 to 0.08)

0.97

P=0.8995

70 vs 90

0.020 (-0.08 to 0.12)

0.81

P=0.9362

30 vs 50

-0.018 (-0.12 to 0.08)

0.73

P=0.9537

50 vs 90

-0.006 (-0.11 to 0.09)

0.24

P=0.9981
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Inhibition Study - Hsd3bl Expression

Paired t test

For differences between control and inhibited:
Mean o f differences = 0.354
Standard deviation = 0.941504
Standard error = 0.421053

95% Cl = -0.815032 to 1.523032

df = 4
t = 0.840748

One sided P = 0.2239
Two sided P = 0.4478
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Inhibition Study - Cypl 7 Expression

Paired t test

For differences between control and inhibited:
Mean o f differences = 0.236
Standard deviation = 0.126214
Standard error = 0.056445

95% Cl = 0.079284 to 0.392716

df = 4
t = 4.181086

One sided P = 0.007
Two sided P = 0.0139
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Inhibition Study - Hsd3bl / Cypl 7 Expression

Paired t test

For differences between control and inhibited:
Mean o f differences = 0.142
Standard deviation = 0.044944
Standard error = 0.0201

95% Cl = 0.086194 to 0.197806

d f= 4
t = 7.064764

One sided P = 0.0011
Two sided P = 0.0021

104

Correlation Analyses

Correlation analyses performed with Microsoft Excel. Slope and R value included on
each graph. P-value included when statistical significance was found.
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hsd3b1 by body (maturation)
3.00

y = 0.0191x + 1.097

hsd3b1 expression

R2 = 0.0079

16.00

18.00

24.00

body mass (g)

hsd3b1 by body (inhibition)

hsd3b1 expression

y = 0.0738x + 0.1687
R2 = 0.1619

10.00

12.00

16.00
body mass (g)

18.00

20.00

22.00
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hsd3b1 by adrenal (maturation)
3.00

y = 0.0841x+ 1.126
R2 = 0.0192

2.50

2.00

g 1.50

1.00

♦♦
0.50

0.00

2.0

2.5

3.0

4.0

4.5

5.0

bsd3b1 by adrenal (inhibition)
3.00

2.50

y= 0.0961x+ 1.1139
R2 = 0.0281
hsd3b1 expression

2.00

1.50
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